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Object ive and m e t h o d : Laser Doppler flowmetry is a non-invasive tool in assessing the 
temporary changes of skin microcirculation. Another non-invasive equipment the Finapres 2300 
finger blood pressure monitor provides a continuous blood pressure signal. The combination of 
the two devices allows short-term monitoring of the changes in the resistance of skin 
microvasculature. In order to assess the role of skin blood vessels in physiological responses to 
complex reflex tests Valsalva manoeuvre was performed by 12 healthy volunteers. For 
comparison a thermal stimulation (cold pressor) test was also done. 
Results: The two tests resulted in skin blood flow responses of similar magnitude. The 
changes in calculated regional peripheral resistance (dRPR) indicated that both responses 
involved active vasoconstrictor mechanisms. It is of importance that the active vasoconstriction 
could be documented only at the late strain phase (V2) but not in the early strain phase (VI) of 
the Valsalva manoeuvre (%dRPR in V I = 0 . I 4 vs. V2=0.96, p<0.05). 
Conclusions: In conclusion our findings support the theory that changes in the tone of 
the skin blood vessels parallel the changes in systemic vasculature in response to complex reflex 
tests. This is the first report which documents the feasibility of the continuous monitoring of the 
regional peripheral resistance. 
Keywords : laser Doppler flowmetry, Valsalva manoeuvre, cold pressor test, regional 
vascular resistance 
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Laser Doppler flowmetry (LDF) provides a continuous non-invasive quantitative 
measurement of tissue blood flow with high spatial and temporal resolution of the 
microcirculation [1, 2, 3, 4]. The laser Doppler method used to measure perfusion in 
discrete sections revealed several categories of rhythmic variations in the flow of 
human skin [5, 6, 7], There are also indications that skin is involved in microcirculatory 
responses induced by cardiovascular reflexes in normal and pathological conditions [8, 
9], The technique, which primarily monitors flow in the arteriolar-capillary network 
quantifies the frequency shift of laser light caused by moving blood cells in the vessels. 
The LDF is highly sensitive to movement, positioning, and myriad other factors that 
can alter skin perfusion. The LDF technique has limitations and can be modified by 
several uncontrollable factors. The best application of LDF is therefore to determine the 
relative changes in microcirculatory blood flow to certain characterized stimuli instead 
of the determination of absolute blood flow [8, 9]. As skin blood flow can be measured 
simply, non-invasively, simultaneously and continuously it provides several advantages 
in autonomic reflex tests. The reduction in skin blood flow in response to the various 
stimuli can be used as an index of arteriolar tone, which in turn is determined by 
sympathetic nerve traffic. 
The traditional laboratory reflex tests are accompanied by rapid blood pressure 
fluctuations. Formerly these blood pressure swings could be detected only by intra-
arterial monitoring. The invasive technique however has several limitations. Technical, 
legal and ethical considerations have so far prevented its widespread use. More 
importantly the intravascular instrumentation itself may significantly alter the 
autonomic regulation [10]. Most recently however a continuous non-invasive blood 
pressure monitor, the Finapres has become commercially available. The reliability of 
this device has been already tested during laboratory conditions with satisfactory results 
[11]. The combination of the laser Doppler flowmetry and continuous blood pressure 
monitoring allows continuous determination of the local peripheral vascular resistance. 
The resistance changes in turn may help in differentiation of active and passive blood 
flow responses. 
The aim of the present study therefore was to assess the feasibility of continuous 
monitoring of the cutaneous vascular resistance in healthy volunteers. Our further goal 
was to characterise passive and active local alterations of the cutaneous vascular 
resistance during autonomic reflex tests. 
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Methods 
Healthy subjects were recruited to participate in this study. The study group 
consisted of 12 (6 male and 6 female) healthy subjects, who ranged from 18 to 28 years 
of age. 
The subjects were studied in supine rest position, in the afternoon, 3 to 4 hours 
after meal. For our recordings, the study was not begun until stable baseline of blood 
pressure and skin blood flow signals for each subject was obtained. Two sets of 
measurements (Valsalva manoeuvre and cold pressor test) were taken on each subject. 
Each test was done in duplicate. The measured parameters returned to the baseline 
within 3 minutes following the tests. Another test was not performed until stability had 
been regained. 
Regional peripheral resistance (RPR) was calculated in the strain (V1 point) and 
at the late strain phase (V2 point) of the Valsalva manoeuvre (Fig. 1) For 
characterisation of vasoconstrictor response to cold pressor test the lowest value of skin 
blood flow was used. 
Measurement of skin blood flow 
Relative blood cell perfusion was measured with a Periflux PF 3 LD monitor 
(Perimed, Stockholm, Sweden). This method uses the frequency shift of laser light 
(2 mW helium-neon laser source of 632.8-nm wavelength) induced by reflection on 
moving red blood cells to measure red blood cell flux. Skin laser Doppler flow values 
cannot be expressed in conventional physiological units unless certain specific 
conditions are fulfilled. In vivo, the readings are therefore expressed in perfusion units 
related to the Brownian motion in motility standard emulsion provided by the 
manufacturer. At standard temperature the emulsion produces a motility of 250 
perfusion units. This corresponds to a 2.5 V at the analogue perfusion output. The 
measurement field of the laser Doppler skin probe is restricted to 1 mm3 of the skin 
microvascuiature [12]. 
The laser Doppler probe and probe holder were attached to the index finger pad 
of the left hand. In preliminary studies, we examined skin vasomotor reflexes at 
different sites including the forehead, forearm and index finger pad. Responses of these 
sites were fairly uniform, therefore we continued the measurements at the index finger 
pads, which contain only vasoconstrictor fibers. Skin temperature was found to modify 
the vasoconstrictor responses substantially. At a skin temperature of less than 28 °C, 
skin blood flow was very low and vasomotor responses were often unobtainable. At 
skin temperature of more than 40 °C blood flow was very high, and skin vasomotor 
reflexes were attenuated. Responses seemed to be optimal at 34 to 36 °C. 
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Continuous blood pressure monitoring 
The blood pressure was measured continuously with Finapres 2300 non-invasive 
blood pressure monitor developed by Wesseling and coworkers. The measurement is 
based on the Penaz principle. The blood volume under an inflatable finger cuff is 
measured with an infrared photoplethysmograph, which is mounted inside the cuff. The 
blood volume as seen by the plethysmograph is clamped to setpoint value by 
appropriately adjusting cuff pressure in parallel with intraarterial pressure by means of 
an electropneumatic servosystem. The volume clamp setpoint is regularly adjusted to 
keep the pressure difference across the arterial wall, the transmural pressure, at zero. At 
zero transmural pressure, cuff pressure equals intraarterial pressure, which is then 
determined indirectly by measuring cuff pressure [13, 14], 
Valsalva manoeuvre 
Each subject was asked to maintain a column of mercury at 40 to 50 mm for 15 
seconds with forced expiration, and then to resume normal expiration. A small air 
leakage was allowed to prevent closure of the glottis. 
The Valsalva manoeuvre is commonly used for assessing autonomic function in 
humans. The effects of the Valsalva manoeuvre on arterial blood pressure is well 
documented. [15] Initially, arterial pressure increases steeply for a few seconds and this 
is attributed mainly to the effects of the imposed pressure on the intrathoracic and 
intraabdominal arteries. The pressure then falls due to decreased venous return. Toward 
the end of the strain phase blood pressure recovers as heart rate and vascular resistance 
increase to compensate for the lower cardiac output. On release of the Valsalva 
manoeuvre, pressure transiently falls, then increases to above control. The overshoot 
phase is accompanied by rebound bradycardia. In our experiments initial blood 
pressure increase set the V 1 point, and the deepest point of the second phase on blood 
pressure recording set the V2 point (Fig. 1) [15], 
Cold pressor test 
The subjects were asked to immerse their right hand (the hand contralateral to the 
laser Doppler velocimeter) into a basin of ice cold water (0 Celsius degree) to the level 
of the right wrist for 20 seconds. Immersion of part of the body in ice cold water causes 
an increase in arterial blood pressure and efferent sympathetic activity (Fig. 2)[16]. 
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Fig. 1. The heart rate, mean arterial blood 
pressure, skin blood f low, and skin 
vascular resistance changes are presented 
during Valsalva manoeuvre. The lines 
indicate the onset and the release o f the 
manoeuvre. The initial blood pressure 
increase ( V I ) and the deepest point o f the 
strain phase (V2) on the blood pressure 
trend curve are set 
Fig. 2. The heart rate, blood pressure, 
skin blood flow and regional peripheral 
resistance during the cold pressor test are 
presented. The lines indicates the onset 
and the end of the ice water immersion 
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Calculation of the regional peripheral resistance 
The skin blood flow (SBF) and mean arterial pressure (MAP) were used to 
calculate the regional peripheral resistance 
RPR = MAP/SBF 
The skin blood flow (SBF) and mean arterial pressure (MAP) were also used to express 
the relative change in regional peripheral resistance (dRPR %) during the examined 
reflexes according to the following formula: 
dRPR = (RPRx - RPRbase)/RPRbase 
where x means any points of the reflex tests. 
For characterization the vasomotor responses in our study we used the previously 
defined VI and V2 points during the Valsalva manoeuvre. For characterisation of vaso-
constrictor response to cold pressor test the maximal change in skin blood flow was used. 
Statistical analysis 
Normally distributed data were compared by using the one-way repeated 
measurement ANOVA. To isolate which group is differ from the others we used a 
multiple comparison procedure (Bonferroni's f-test). Non-Gaussian data were analyzed 
by using the Friedman repeated measurement ANOVA test. Student-Newman-Keuls 
method was performed as all pairwise multiple comparison method. 
Results 
Valsalva manoeuvre (Tables I and III) 
The typical skin blood flow and blood pressure responses to Valsalva manoeuvre 
is shown in Fig. 1. Skin blood flow responses followed a pattern of four phases that 
corresponded to the four blood pressure phases of the Valsalva manoeuvre. 
Comparison of skin blood flow, mean arterial pressure and calculated regional 
peripheral resistance at the baseline, VI point and at V2 point levels are summarized in 
Table I. The initial phase of the Valsalva manoeuvre resulted in a significant increase in 
mean arterial pressure and skin blood flow, however the calculated regional peripheral 
resistance remained unchanged. Toward the end of the strain phase there was a drop in 
mean arterial pressure below baseline. At this point there was also a marked decrease in 
skin blood flow. The calculated regional peripheral resistance showed significant 
elevation. 
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Table I 
The mean arterial pressure, the skin blood flow and the regional peripheral resistance at the three 
characteristic points of the Valsalva manoeuvre 
Baseline VI V2 
MAP 77.595 ± 8.3 104.79 + 9.2* 70.96 ± 9.29* 
(mmHg) 
SBF 546.55 ± 275.22 655.195 ± 222.62* 329.27 ± 294.42* 
(PU) 
RPR 0.18 ± 0.096 0.178 + 0.062 0.37 ± 0.23* 
MAP = mean arterial pressure; SBF = skin blood flow; RPR = regional peripheral resistance * = p<0.05 vs 
baseline 
Table II 
The mean arterial pressure, the skin blood flow and the regional peripheral resistance responses to cold 
pressor test 
Baseline Cold pressor test 
MAP 70.33 + 7.17 96.396 + 10.48* 
(mmHg) 
SBF 524.25 + 252.92 390.709 + 246.53* 
(PU) 
RPR 0.168 ± 0.083 0.36 + 0.228* 
MAP = mean arterial pressure; SBF = skin blood flow; RPR = regional peripheral resistance * = p<0.05 vs 
baseline 
Table III 
The extent of the mean percentage changes in regional 
peripheral resistance (dRPR%) at different points of the 
cardiovascular reflex tests 
dRPR% 
VI 0.139 
V2 0.956 
Cold pressor test 0.962 
dRPR% = (RPRx - RPRbase)/RPRbase 
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Cold pressor test (Tables II and III) 
Cold immersion of the contralateral hand resulted in significant increase in mean 
arterial pressure. The skin blood flow at the same time exhibited a significant reduction. 
As a consequence the calculated regional peripheral resistance showed a marked -
more than double-fold - elevation. In Table III we summarized the extent of the 
percentage change in regional peripheral resistance at different points in our reflex 
tests. 
Discussion 
According to the traditional view changes in the resistance of skin vessels are 
governed mainly by thermoregulatory reflexes [17, 18]. Thus the relative changes in 
skin blood flow during complex reflex tests such as Valsalva manoeuvre could be 
regarded as reflections of the changes in systemic blood flow. Recently however Low 
et al. have documented that these changes in skin blood flow are results of active local 
regulating mechanisms [19]. Our goal was to assess the responses of the skin 
vasculature to thermal and baroreflex changes. Changes were characterized by 
calculating relative resistance from the continuously recorded blood flow signals. Our 
findings are in concordance with that of Low et al. The thermal and the baroreflex 
responses involved comparable temporary fluctuations in skin blood flow. 
Physiological responses to cold exposure are well documented [16, 17, 18], It is of 
importance that the initial strain phase of the Valsalva manoeuvre was parallelled by 
proportional changes in the skin blood flow and finger blood pressure. Thus the 
calculated skin resistance remained unchanged. Toward the end of the strain phase 
however the decrease in blood pressure was accompanied by an inproportionally 
marked decrease in blood flow, signalling increasing skin resistance. The same 
tendency has been already documented in the changes in systemic vascular resistance 
during the Valsalva manoeuvre [20, 21]. Cutaneous blood flow shows a parallel 
behaviour with blood pressure modification under Valsalva manoeuvre while it clearly 
decreases when blood pressure rises during cold pressore test. The opposite relationship 
between cutaneous blood flow and blood pressure behaviour during the two stimuli is 
probably determined by different reflexogenic modifications triggered by the Valsalva 
manoeuvre and cold pressor test. The response to the cold exposure certainly involves 
similar active vasoconstriction. The extent of the active vasoconstriction characterised 
by the percentage changes of regional peripheral resistance was very similar during the 
two tests. 
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Low et al. were the first to suggest a possibility to calculate skin vascular 
resistance [19]. In their study they utilized traditional blood pressure measurements 
with mercury sphygmomanometer, which allows only infrequent sampling. Owing to 
the continuous blood pressure measurements our findings are more accurate then the 
previous data. Indeed the continuous monitoring of the skin vascular resistance with 
our system seems to be realistic. The feasibility of this monitoring however is not yet 
evaluated, and merits further studies. 
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The existence of an active vasodilator system in the human skin microvasculature is well 
documented, but its physiological role and the underlying mechanisms are not completely 
understood. Cutaneous blood flow increases during isometric handgrip exercise. To examine 
whether this response is mediated by active vasodilation, isometric handgrip exercise testing was 
performed in nine healthy subjects. Local iontophoresis of atropine was applied to the forearm 
skin. Skin blood flow (SBF) monitoring by means of laser Doppler flowmetry was combined 
with continuous noninvasive blood pressure monitoring. SBF monitoring was performed at a site 
pretreated with atropine and an adjacent control area. Mean arterial pressure (MAP) was recorded 
noninvasively. Cutaneous vascular resistance (CVR) was calculated as MAP/SBF for the 
atropine treated and the control areas. Changes in CVR were expressed as percent deviation from 
the baseline (dCVR). Isometric handgrip exercise resulted in a marked reduction in CVR at the 
control site (dCVR: -66+4%). In contrast, the CVR was not significantly altered at the atropine-
treated site (2.4±7%). It is concluded that isometric exercise induces an atropine-sensitive 
vasodilation which is mediated by muscarinic receptors in the human skin. 
Keywords : cholinergic, vasodilation, cutaneous vascular resistance, static exercise 
Cutaneous vasodilation may result from a withdrawal of the sympathetic 
adrenergic activity and/or activation of an independent vasodilator system. Active 
vasodilation plays an important role in thermoregulatory responses [5], In contrast, the 
mechanism of cutaneous vasodilation during static exercise is controversial [3, 4, 9]. 
The onset of the static exercise is accompanied by vasodilation, mediated by 
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sympathetic cholinergic nerve fibers in the muscles [8]. Cholinergic vasodilation may 
also be operative in the skin during isometric handgrip exercise. 
Methods 
Nine healthy male volunteers, ranging in age from 19 to 32 years, were recruited 
to participate in the study. All subjects provided written informed consent. Blood 
pressure (MAP), heart rate, skin blood flow (SBF), skin temperature were continuously 
monitored. Since the responsiveness of the skin microvasculature may vary with the 
ambient temperature [5], we studied the reflex responses at constant skin temperature 
(see below). To block muscarinic receptors, atropine was applied to a 0.6 cm2 circular 
area of the non-exercising forearm skin by means of iontophoresis 30 min before the 
onset of recording [5]. The subjects were studied in a supine resting position, in the 
afternoon, 3 to 4 h after food intake. The subjects were instrumented for measurements 
of heart rate, finger blood pressure, skin temperature and SBF. The recording was 
started when stable baselines for blood pressure, heart rate and SBF were observed. 
Subsequent to a 5-min period of baseline data collection, isometric handgrip exercise 
was performed by each individual. Post-exercise data acquisition was continued until 
all parameters had returned to baseline values. 
Relative blood cell perfusion was measured by means of a double-channel skin 
perfusion monitor (Perimed). The laser Doppler probes and the probe holders were 
attached to the ventral side of the treated (non-exercising) forearm. SBF was 
determined in the atropine-treated and in control areas. The control area was 
approximately 5 cm proximal to the treated region. The temperature probe was placed 
in between the two laser Doppler probe holders. Blood pressure was measured 
continuously on the non-exercising side by means of a Finapres 2300 (Ohmeda) 
noninvasive blood pressure monitor. The ECG was monitored by a Siemens Sirecust 
730 ECG monitor. The R wave of the electrocardiogram and the plethysmographic 
signals were fed via an amplifier, a filter and analog to digital converter into an 
IBM-AT compatible computer. 
All subjects performed isometric handgrip exercise (IHG) at 30% maximal voluntary 
contraction for 2 min with an exercise dynamometer. Maximum voluntary contraction was 
determined for each subject just before the beginning of the experimental session. Subjects 
were instructed to avoid a Valsalva manoeuvre during IHG. 
Cutaneous vascular resistance (CVR) was determined as the ratio of MAP and SBF. 
The percentage change in CVR (dCVR) was expressed as follows: 
dCVR= (CVRx - CVRbaseline)/CVRbaseline 
where x denotes the maximum change during the test. 
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Statistical analysis 
Data with normal distribution were compared by using the one-way ANOVA for 
repeated measures. Non-Gaussian data were analyzed using the Friedman' test. An alfa 
level of p<0.05 was considered to be significant. 
Results 
Skin temperature (mean+S.E.M) of the volunteers was 33.9+1.2 °C; no 
significant fluctuations were detected during static exercising. 
The SBF and MAP responses to IHG are shown in Figures 1 and 2. MAP 
increased continuously during the manoeuvre (baseline: 91±4 mm Hg, maximum: 122± 
4 mm Hg, p<0.05). On termination of isometric exercise, MAP returned to baseline 
level. SBF increased significantly in the control area (baseline: 335±88 a.u., maximum: 
1396±286 a.u., p<0.05) and a rapid post-exercise recovery was observed. SBF did not 
change significantly in the atropine-treated region throughout the test (baseline: 509±38 
a.u maximum: 531±132 a.u., p=NS). CVR decreased significantly at the control site 
(-0.66+0.1 a.u., p<0.05 vs. baseline). In contrast, no significant CVR changes were 
seen in the region treated with atropine (0.02±0.06 a.u., p=NS). The maximum changes 
in CVR differed significantly between the atropine-treated and control areas. 
Discussion 
The objective of the present study was to determine microvascular responses of 
the non-exercising forearm skin during contralateral isometric exercise and to 
characterize the underlying mechanisms. A cholinergic cutaneous vasodilation response 
was hypothesized to accompany static exercise. We therefore utilized a self-controlled 
study design, comparing atropine-treated and control skin areas. The major finding of 
our study is that isometric exercise-induced human skin vasodilation is cholinergically 
mediated. This result is at variance with previous reports [7], Roddie et al. reported 
vasodilation in the forearm tissues during body heating. This response was not 
prevented by intraarterial administration of atropine, but was abolished the sweating 
reaction effectively. A non-cholinergic, non-adrenergic vasodilator nerve activity was 
postulated as the probable mechanism [7]. 
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Fig. 1. Typical heart rate, MAP, and SBF 
response to 2 -min IHG at the control site. M A P 
increases cont inuously during the maneuver. 
On termination o f IHG M A P returns to the 
baseline level . S B F increases, and a rapid post-
exercise recovery period can be observed. The 
change in C V R s h o w s active vasodilation 
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Sanders et al. found an active vasodilation in the non-exercising forearm muscles 
at the beginning of isometric handgrip exercise, despite the well-known activation of 
sympathetic vasoconstrictor fibers. They have documented that this response is 
primarily mediated by cholinergic mechanisms. Withdrawal of the adrenergic 
vasoconstrictor tone and the activation of P2 receptors could both be excluded [8]. It 
has been reported that an acethylcholine-mediated active vasodilation is operational in 
the skin microvasculature [2, 6]. Our present findings further extend the observation of 
these studies. The cutaneous cholinergic vasodilation system could be triggered by 
isometric exercise. 
Acetylcholine induced vasodilation is currently attributed to the release of 
endothelium derived relaxing factors including nitric oxide [1], By analogies drawn 
from this study, there is a possibility of nitric oxide-mediated dilation of the human 
skin microvasculature as well. 
In conclusion, our results provide further evidence in favour of the presence of a 
cutaneous cholinergic vasodilator system which can be activated by isometric exercise. 
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1. Although the increased heart rate variability in healthy subjects in association with 
slow patterned breathing and continuous positive airway pressure is well documented, there is no 
general agreement regarding the underlying mechanism. The arterial baroreceptor stimulation 
due to greater blood pressure variability, the stimulation of pulmonary stretch and low pressure 
baroreceptors can play important role in this phenomenon. 
2. In order to assess the interplay between blood pressure and heart rate changes we have 
studied nine healthy volunteers (mean age was 22 yrs. range 19-24), by applying 6/min 
patterned breathing, and continuous positive airway pressure of 10 cm of water. ECG and finger 
blood pressure (Finapres 2300) was continuously recorded. The oscillation amplitude of R-R 
intervals were analysed as well as the time and frequency domain indexes of heart rate 
variability. The oscillation amplitude and the corresponding frequency domain components of 
systolic blood pressure were also calculated. 
3. The forced deep breathing caused significant increase in heart rate variability as 
indicated by time and frequency domain analysis of R-R intervals (LF HRV ms2: spontaneous: 
777.401526.1, patterned breathing 6828.0015468.0). The application of CPAP in the same 
rhythm during patterned breathing resulted in further enhancement in heart rate variability 
(LF HRV ms2: 9052.0014533.0). The analysis of the same frequency domain components of 
systolic blood pressure showed marked elevation of the total and low frequency power during 
patterned breathing. (LF BPV mm Hg2: spontaneous: 8.2416.2, patterned breathing: 16.2219.7). 
Applying CPAP with the same breathing pattern elicited further significant increment in systolic 
blood pressure fluctuation (LF BPV mm Hg2: deep breathing+CPAP: 27.1119.8). The baroreflex 
sensitivity as calculated from spontaneous HR and BP sequences was 11.6612.9 at baseline and 
increased to 17.6616.1 and changed to 15.2213.2 with the addition of patterned breathing and 
CPAP, respectively. 
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4. Our findings indicate that the heart rate and blood pressure responses to slow patterned 
breathing may be interpreted as consequences of an altered baroreflex sensitivity. In contrast the 
active breathing with CPAP exerts mechanical effects which in turn present an augmented 
systemic baroreflex trigger, however, the baroreflex sensitivity remains unchanged. 
Keywords: spectral power, heart rate variability, blood pressure variability, continuous 
positive airway pressure, autonomic netvous system 
It has been long known that respiration is associated with heart rate and blood 
pressure changes [1,2]. The respiratory sinus arrhythmia involves inspiratory heart rate 
acceleration, and expiratory (or postinspiratory) heart rate deceleration [3]. It has also 
been realized that the extent of the pulse rate fluctuations is related to the frequency and 
depth of breathing, the highest amplitude changes being reached around the breathing 
frequency of 6/min [4, 5], The breathing rate also bears influence on the blood pressure 
responses. The amplitude of the blood pressure swings increases with decreasing 
respiratory rate, with a maximum again around the 6/min. respiratory frequency [3]. It 
has been noted by Dornhorst et al. that the relation between the blood pressure 
variation and the respiratory phase is a function of the respiratory rate [3]. More 
recently Laude et al. documented that systolic blood pressure decreases during 
inspiration with a time delay which increases as breathing frequency decreases [6]. 
The effects of the positive pressure ventilation and continuous positive airway 
pressure on the circulation and the cardiovascular autonomic regulation are well 
recognized, however the exact mechanisms remain subject of controversy [7, 8], 
Continuous positive airway pressure (CPAP) exerts mechanical effects in healthy 
subjects by increasing the left ventricular filling pressure and the right atrial pressure, 
the downstream pressure for venous return [9]. The effect of active and passive 
breathing with CPAP may induce different responses [10], and the role of the breathing 
frequency while applying CPAP is not known. 
Monitoring the oscillations of hemodynamic parameters is a new field in 
anesthesiology. Since the magnitude of blood pressure oscillation caused by the 
mechanical effect of positive pressure ventilation is dependent on the volume status of 
the patients, a number of recent studies focused on this relationship [11]. Another 
approach, the spectral assessment of heart rate variability, has already gained different 
applications [12, 13]. Although the hemodynamic effects of both components have 
been extensively studied their interactions remains unclear. In order to assess the 
additional effects of slow patterned breathing and continuous positive airway pressure a 
series of studies was performed on 9 healthy volunteers. 
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Methods 
Subjects 
Healthy subjects were recruited to participate in this study. The study group 
consisted of nine male volunteers who ranged from 19 to 24 years in age (mean: 22 
years). Their assessment revealed no pulmonary, cardiovascular or neurologic disease. 
None were taking medications. The subjects were studied in supine rest position, in the 
afternoon, 3 to 4 hours after meal. For our recordings, the study was not begun until the 
most stable baseline of blood pressure and heart rate signals for each subject was 
obtained. The subjects were non smokers. All subject gave their written informed 
consent prior to the experiments. 
Measurements and calculation 
The electrocardiogram was continuously recorded with a Siemens Sirecust 730 
monitor. Blood pressure was measured noninvasively with a Finapres 2300 (Ohmeda) 
device, which has been referred to reflect blood pressure spectral changes reliably. The 
R wave of the electrocardiogram and the plethysmographic signals were fed through an 
amplifier, filter and analog-digital converter into an IBM-AT compatible computer. 
Data were stored and analysed by a self-developed program written in Microsoft 
C/C++ 7.0. The computer measured the interval between successive R waves with a 
precision of 2 ms. The accuracy of ECG signals detection was 40 microvolts and 
1 mm Hg. The cardiotachogram and trend-grams of the blood pressure values were 
continuously recorded on-line. The oscillation amplitude of R-R intervals and systolic 
blood pressure were analysed. The spectral analysis of R-R interval and systolic blood 
pressure variability were computed by using fast Fourier transformation, using the 
Hanning window over two frequency bands: low frequency power (0.04 to 0.14 Hz) 
and high frequency power (0.15 to 0.4 Hz). We considered a total frequency power 
range from 0.01 to 0.4 Hz. The short-term measures of time domain indexes as the 
average normal R-R intervals (mean R-R), the standard deviation of the consecutive 
normal R-R intervals (SD), % of consecutive normal R-R interval differences >50 ms 
(pNN50), root mean square successive differences (rMSSD) were also calculated. 
Baroreflex sensitivity (BRS) was characterised by the spontaneous sequences 
method as described earlier [14, 15]. It has been stated that 3 or more cardiac cycles of 
unidirectional BP increase or decrease with the corresponding lengthening or 
shortening of the interbeat intervals form spontaneous "up-" or "down-sequences" [15]. 
These sequences are analogous to those induced by pharmacological manoeuvres, and a 
spontaneous baroreflex sensitivity could be determined as an average of several 
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individual slopes [14]. In this study each step changes in systolic blood pressure (delta 
SBP) were paired with the changes in the subsequent RR intervals (delta RR). This 
method is referred as lag 1 technik [15]. 
Protocol 
The subjects were studied in supine rest position. The subjects were asked to 
close their eyes, relax not to cough during the measurements. The R-R intervals and 
the finger blood pressure were monitored and recorded continuously over ten minutes 
baseline period followed by 30 minutes of study period. Three sets of measurements 
were taken: during spontaneous, then during patterned breathing (6/min) without 
CPAP, and finally during 6/min patterned breathing while applying CPAP. High flow 
system was used to keep CPAP level constant throughout the respiratory cycle, 
avoiding flow dependency of the airway pressure. Ten cm of water CPAP was applied 
through a mouthpiece using the Veolar (Hamilton) ventilator while the subject's nose 
was clamped. Subjects were instructed not to change the depth of breathing with the 
addition of CPAP. The magnitude of applied pressure was monitored by the Leonardo 
graphical computer program attached to the ventilator. 
Statistical analysis 
Sheffe's test was used to compare the three independent variables. For data 
showing non-normal distribution, and the skewness coefficient was >1 the statistical 
tests were done only after logarithmic transformation. We considered the differences 
statistically significant when p was less then 0.05. Data are given as means and 
standard errors. 
Results 
The effect of patterned breathing and CPAP on HRV (Fig. 1. Table I) 
The mean of the R-R intervals did not show any changes between the three 
different situations. The standard deviation of the R-R intervals showed significant 
increment between the patterned (6/min) and spontaneous breathing. The other time 
domain parameters such as pNN50 and rMSSD did not change significantly between 
the spontaneous and patterned breathing. There were no significant, just tendentious 
differences between the time domain parameters measured at metronomic ventilation 
and during the application of CPAP with the same rhythm of respiration. Thus the time 
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domain indexes of the heart rate variability showed significant differences only 
between the spontaneous respiration and patterned breathing with CPAP. The 
frequency domain parameters of the HRV showed significant elevation on transition 
from spontaneous to patterned mode. Similar differences were seen between the 
spontaneous and CPAP mode in the total and low frequency range. In the high frequen-
cy range the HRV did not exhibit any significant modification throughout the study. 
Tab ic I 
Heart rate am! blood pressure variability and harorejlex sensitivity during the three different situations 
Spontaneous Scheffe Metronóm SchefTe Metronóm 
breathing F test breathing F test breathing+CPAP 
R - R mean (ms) 847.5134.7 0.85 798.6126.1 0.51 786.7114.0 
SBP mean (mm Hg) II 6.1 ±6.0 0.065 113.215.5 0.125 117.115.2 
R-R oscill (ms) 80.7±I0.1 12.9* 238.1126.72 1.63 294.1124.9 
SBP oscill (mm Hg) 6.83±1.16 7.32* 14.511.36 4.24* 20.311.66 
SD RR (ms) 46.4+4.3 6.61* 90.6111.87 0.81 106.217.8 
pNN'50% 25.3+5.03 0.436 31.114.5 0.702 38.413.36 
rMSSD (ms) 44.1+4.3 1.48 61.319.4 0.34 69.616.4 
TFhrv (nts2) 17031256.7 3.87* 8059.812232.4 0.526 10402.111664.6 
LFhrv (ms2) 777.41175.3 4.87* 682811822 0.65 9052.411511 
HFhrv (ms2) 595.81173.8 0.52 10001422.7 0.029 904.31155.3 
TFbpv (mm Hg2) 15.4613.2 0.85 23.314.79 3.S3* 39.314.6 
LFbpv (mm Hg2) 8.2412.07 1.85 16.2213.25 3.46* 27.1113.2 
HFbpv (mm Hg2) 2.3710.91 0.28 1.6310.38 1.324 3.2310.61 
BRS spont (ms/mm Hg) 11.611.2 4.12* 17.612.06 0.649 15.211.09 
CPAP=continuous positive airway pressure, SBP=systolic blood pressure, hrv (bpv)=heart rate (blood 
pressure) variability, BRS=baroreflex sensitivity, TF, LF, HF=total, low, high frequency power, *significant 
at 95% 
The effects of the patterned breathing and CPAP on the blood pressure variability 
(Fig. 1) 
The mean and the standard deviation of the systolic blood pressure remained 
unchanged during the study. The application of 6/min metronomic ventilation did not 
alter the BPV compared to spontaneous respiration. The application of CPAP caused 
marked increment in the power of the total and low frequency ranges of the blood 
pressure variability compared to both the baseline parameters and to those recorded 
during patterned breathing. The blood pressure power in the high frequency range did 
not change during the three different situations. 
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Fig. 1. The R-R intervals and systolic blood pressure (SBP) trendgrams are shown during the three 
breathing conditions in a single subject. CPAP: continuos positive airway pressure 
The oscillation amplitude of the R-R intervals and the systolic blood pressure (Fig. 2) 
The oscillation amplitude of the R - R intervals showed significant increase 
during 6/min breathing. The application of CPAP did not cause further increment in the 
oscillation of R - R intervals. In contrast, the oscillation amplitude of the systolic blood 
pressure increased during patterned breathing, and showed further significant elevation 
due to the application of CPAP. 
Analysis of baroreflex sensitivity and baroreceptor gain 
The baroreflex sensitivity determined by the method of spontaneous sequences 
showed statistically significant elevation on transition from spontaneous to patterned 
breathing. No further changes were detected while breathing with CPAP. 
Discussion 
The genesis of respiratory sinus arrhythmia is complex. The following 
mechanisms have been implicated: 1. Central cardiorespiratory coupling. 2. Reflexes 
from pulmonary stretch receptors. 3. Arterial baroreflexes. 4. Reflexes from the cardiac 
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Fig. 2. The power spectral densities of R - R intervals and systolic blood pressure (SBP) are shown dur ing 
the three breathing condit ions in a single subject. CPAP: continuos positive airway pressure 
(low pressure) baroreceptors [16]. The relative roles of these mechanisms remain 
unclear. The mechanism of augmented heart rate fluctuation at slow breathing rates - a 
proposed marker of cardiac vagal integrity - is also subject of debate. In our study, in 
concordance with previous publications, the patterned breathing with the frequency of 
6 cycles/min. elicited a significant increase in the amplitude of both HR and BP 
fluctuations [3,6]. The same effect has been reflected by the increment in the BPV and 
HRV total power. The marked respiratory effect appeared in the low frequency spectral 
band, corresponding to the slow breathing rate. There is a superposition of the 
breathing induced hemodynamic changes on the other low frequency oscillations 
governed mainly by baroreflex mechanisms [17]. This amplification, or resonating 
baroreflex control loop mechanism explains the accentuated 0.1 Hz BPV and HRV 
peaks. The efferent mechanisms of this regulations involve both parasympathetic 
influences on the heart rate, and sympathetic influences on the heart rate and peripheral 
vascular tone [17]. Thus the designation of this peak in the given setting as 
"sympathetic" or "parasympathetic" is meaningless. Although the amplitude of HR 
changes in response to the slow patterned breathing is widely used to characterize 
cardiac parasympathetic tone [18], there have also been controversies regarding this 
marker. Kollai and Mizsei demonstrated that respiratoiy sinus arrhythmia is a limited 
measure of cardiac parasympathetic control in man [19]. One of our most interesting 
results is that the baroreflex sensitivity was substantially higher during slow deep 
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breathing than during spontaneous breathing. The increased BRS during 6/min 
breathing could be expressed as a 50% greater HR change in response to a given rise or 
drop in blood pressure. The mechanism of the exaggerated baroreflex responsiveness 
might have been related to the altered activity of cardiopulmonary baroreceptors. 
Vatner et al. documented a progressive reduction of the arterial baroreflex sensitivity 
with acute volume loading [20], and Shi et al. found similar tendency using lower body 
positive pressure [21], In contrast Bevegard et al. [22], Takeshita et al. [23], and Eiken 
et al. [24] reported that physiological variation of central venous pressure do not 
influence sinus node responses to arterial baroreceptor stimulation in man. 
Toska and Eriksen first documented that the blood pressure changes during 
spontaneous breathing are related to the changes in stroke volume [25], They found 
that the normal heart rate fluctuation exerts a buffering effect on mean blood pressure 
changes [25]. The anti-oscillatory role of HRV was further substantiated by Saul and 
Triedman [26], and Kardos et al. [27], Beaussier et al. recently reported similar 
causative relationship between stroke volume and blood pressure transients during 
positive pressure ventilation [11]. There is a respiration related fluctuation of the 
preloads and afterloads of the ventricles, and pulmonary vascular capacitance. As 
Domhorst pointed out that the changes in the filling of the left ventricle are determined 
but lags behind that of the right [3]. In addition there is a possible ventricular 
interdependence mediated by the displacement of the ventricular septum, and by the 
pericardial pressure. All of these factors may contribute to the stroke volume changes, 
and in turn to the blood pressure oscillations during spontaneous and positive pressure 
mechanical ventilation. Although application of PEEP causes marked changes in these 
parameters, Innes et al. [28], Yi-Hankala et al. [29], and Taha et al. [10] reported 
reduction of respiratory sinus arrhythmia at the time of positive pressure mechanical 
ventilation. Yi-Hankala et al. [29], and Taha et al. [10] also reported a phase shift of 
HR swings compared to spontaneous breathing. The explanation for this paradox was 
presented by Taha et al who demonstrated an altered profile of systolic blood pressure 
during passive positive pressure ventilation in comparison with spontaneous breathing. 
Thus, in turn the different responses were mediated by the systemic baroreflex. In our 
present experimental design we utilized spontaneous breathing with additional positive 
end expiratory pressure. Therefore the blood pressure fluctuation pattern remained 
normal during the test. The actual amplitude of these swings with CPAP were greater 
than during spontaneous and patterned breathing without positive end expiratory 
pressure. Thus the amplified HR oscillation with the application of CPAP could be 
explained by increased trigger of the systemic baroreflex. The role of low pressure 
baroreceptors again could not be excluded. Nevertheless the spontaneous BRS showed 
no further alterations compared to that of slow patterned breathing. 
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In conclusion our findings indicate that the well-known effects of slow patterned 
breathing may be interpreted as consequences of an altered baroreflex sensitivity. The 
exact mechanism of the phenomenon is not known and necessitates further studies. In 
contrast the active breathing with CPAP exerts mechanical effects which in turn present 
an augmented systemic baroreflex trigger. The involvement of low pressure 
baroreceptors and pulmonary stretch receptors remains unclear. 
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because of the increased number of 
spontaneous losses before procedures at 
that stage. 
We agree with Konje et al about the 
denominator used for calculations, and 
that it would be inappropriate to 
include those lost to follow-up in 
the denominator for table 2. 21 S3 and 
2185 in table 2 represent the numbers 
randomised, but those lost to follow-up 
were not included in calculation of the 
total loss percentage. 
Konje and colleagues comment that 
the intent-to-treat evaluation would 
underestimate the frequency of various 
complications. \\"e agree that various 
denominators can be used to present 
these data but we could present the data 
in numerous ways. Although there may-
be merits to the various comparisons, 
there were 2183 patients randomised to 
the early croup, and 1916 
amniocenteses were done in the early 
gestational window with 11 lost to 
follow-up, 150 had spontaneous and 
therapeutic abortions before delivery, 
and the remaining 2022 were bom. In 
the 2022 babies bom, there were 28 
that had a talipes-like deformity, which 
is a marginally higher percentage than 
we reported. 
The apparent discrepancy between 
the figures in table 3 and the 
denominators for the talipes analysis is a 
reflection of the different measures of 
estimated gestational age• at 
amniocentesis. Table 3 represents 
gestational age calculated on the basis 
of the dating ultrasound at the time of 
randomisation. If the estimated age at 
randomisation was 60 days and the 
amniocentesis was done 20 days later, 
the calculated age at amniocentesis as 
shown in table 3 would be 80 days. The 
alternative measure of the estimated 
gestational age at amniocentesis was to 
use the crown-rump length as obtained 
by ultrasound on the day of 
amniocentesis. This crown-rump length 
measurement was used for the 
presentation of the talipes data to make 
it comparable with the data presented 
by Sudenberg and colleagues.' 
T h e CEMAT group used the total 
fetal loss rate as a primary outcome for 
this trial because it was felt to be the 
most unbiased comparison between 
treatment groups. This trial was not 
designed to evaluate the excess fetal loss 
rate after early amniocentesis because 
the control group for that study would 
have had no procedure. We emphasise 
that although the C E M A T study 
showed a significant difference in total 
losses between the two groups, it is the 
other findings that provide strong 
evidence against the use of early 
amniocentesis for routine first-trimester 
prenatal diagnosis. 
In response to Bernd Eibcn and 
colleagues. the C E M A T trial 
randomised 2183 ar.d 2185 women to 
early and midtrimestcr amniocentesis, 
respectively. T h e strength of the study-
is the fact that only 11 and 23 women 
were lost to follow-up in these groups, 
respectively: complete follow-up 
(99-2%) was available for 2172 and 
2162 pregnancies, respectively. The 
Eiben study was no: a randomised trial 
and fetal outcome was reported to be 
available in about 90% of the early-
amniocentesis group. W e cannot 
assume that adverse outcomes will be 
reported to the physician because on 
many occasions patients and physicians 
may not make the connection of a foot 
abnormality and early amniocentesis. 
Since foot abnormal i t ies are fairly-
common (1 -3 per 1000 livebirths-"), 
complete fol low-up is the only-
mechanism for appropriate comparison. 
In C E M A T . the difference in total 
losses in the two groups was 1 -7%, with 
one-sided CIs up to 2-98%: this is a 
significant difference for the early group 
and cannot be completely explained by 
physiological spontaneous losses. The 
spontaneous postprocedure loss rates 
(2-6% vs 0-8%) are not comparable 
because of different gestational ages at 
procedure. 
T h e amount of fluid removed at the 
t ime of amniocentes is might be 
important, but both the C E M A T trial 
and Sudenberg's study' (which did not 
remove any fluid) had similar foot 
abnormality rates at 1-3% and 1-7%, 
respectively. 
R Douglas Wilson, for the CEMAT 
Study Group 
Division of Materna! Fetal Medicine. BC 
Women's Hospital. Vancouver. BC. Canada 
V6H 2N1 
1 Sudenberg K, Bang J. Smidi-Jensen S, et al. 
Randomised study of risk of fetal loss related 
to early amniocentesis versus chorionic villus 
sampling. Lamci 1997: 350: 697-703. 
2 Cowei! HR, Vi'ein BK. Genetic aspecu of club 
foot. J Banc Jain: Surg 1<>S0; 63: 1381-64. 
Conflicting brain images 
Sir—Miguel Viana Baptista and co-
workers (Feb 7, p 414) ' present an 
interest ing case of a pat ient who 
underwent carotid endanerectomy due 
to unilateral internal-corot id-ar tery 
stenosis. Brain images taken after 
clinical de ter iora t ion showed that 
interstitial oedema appeared not only 
in the whole white mat ter (including 
posterior portion) of the ipsilateral side, 
but also in posterior portion of the 
white ma t t e r cont ra la tera l to the 
endanerectomy. 
Reversible posterior leukocncepha-
lopathv syndrome (RPLS) with 
encephalopathy is usually reversible 
and associated with hypertension, renal 
failure, and eclampsia, as well as the 
administration of immunosuppres-
sants."5 The cause of this syndrome is 
usually an asymmetric lesior. in 'he 
white matter dominant in the posterior 
ponion of h e brain, regarded as a 
vasogenic oedema due to ieakage from 
the capillary."' 
Because perfusion magnetic-
resonance imaging showed h a t h e 
hyperperfused brain had a normal 
blood flow, Baptista and colleagues 
propose a nomenclature of 
"reperfusion syndrome" instead of 
"hyperperfusion syndrome" for he i r 
case. Here, h e term RPLS involves h e 
consequences of iniemal-carotid-artery 
endanerectomy. That RPLS can occur 
with such asymmetry is aiso 
noteworthy. 
'Kazumasa Sudo. Kunio Tashiro 
Department ot Neurology. Kokhaido University 
School of Medicine. Klta 14. Nisni 5. Kits-Ku. 
Sapporo. 060-8548 Japan 
1 Baptists MV, Maeder P. Dewa.-rat: A, 
Bogonsslavsky J. Conflicting images. Lnuct 
199S; 351:414. 
2 Hinchev J, Chaves C, Appignani B, e: a!. A 
reversible posterior leukoencephaiopathy 
syndrome. .V Engl J Mid 1996; 334; 494-500. 
3 Donnan GA . Posterior 
leukoenceohaiopaihy syndrome. Lcntc: 
1996; 347- 988. 
Baroreflex sensitivity and 
heart-rate variability in 
insulin-dependent 
diabetics with 
polyneuropathy 
Sir—The ATRAMI investigators (Feb 
14, p 478)' show h a t measurement of 
baroreceptor reflex sensitivity (BRS) is 1 
an appropriate way to identify' patients 
after.myocardial infarction who were at 
a high risk of cardiac d e a h or a non-
fatal cardiac arrest because of 
documented ventricular fibrillation. 
Autonomic imbalance, however, may-
be asociated with an increased risk of 
sudden death, even without 
myocardial infarction. 
In a 5-year follow-up study, h e 
mortali ty rate of diabetics with 
abnormal autonomic reflexes was 
above 50%.' A meta-analysis of data 
on 1203 patients in nine studies 
revealed that h e mortality rate after 
5-8 years of diabetes w i h autonomic 
neuropathy was 29%, whereas h e rate 
was 6% in diabetics w i h a normal 
au tonomic funct ion. 5 T h e MIDAS 
Study Group* found h a t myocardial 
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C.ORKIiSI'ONDENCl: 
IDDM Controls p 
patients 
Autonomie score 5 7 ¡2-4) 0 <0-001 
BRS (ms/mm Hg) 
Supine posnion 3-7(2-1) 13-3 (12-71 <0.00t 
Standing us 2-2 (2-1) 5-7 (2-8)" 0-002 
SDNN (ms) 
Supine posi-.ion 17-919-1? 40-7 (24-7? 0-002 
Standing up 18 5 (10-0)43-9116-31 <0-001 
Ptrlpheral sensory 
functlon (Hz) 
Median nerve 
2000 H: 1(2-1) 2-7 (0-6i 0-010 
250 Hz 3-3(3-5) 10 (0-4) 0-040 
5 Hz 2-3(3-3) 0-5 (0-21 0030 
Peronea: nerve 
2000 Hr 6-6 (3-1! 3-5(0-7) 0-019 
250 Hz 5-0(3-8) 1-6 (0-5) 0-007 
5 Hz 3-0(3-3) 0-7 (0-2) 0-002 
'<0 05 (BRS after s;anS:ng up is BRS in supine 
position »¡thin the control group). Values are rr.ea.ns 
(SO). 
Neuropathy indices in patients with 
IDDM and controls 
infarction in diabetic patients led to an 
increased mortality rate in diabetics, 
both in hospital and during 3 years of 
follow-up; they also found that 
diabetes meliitus was an independent 
predictor of mortality, and the relative 
risk for individuals aged 30-49 years 
was 1-87. 
We analysed the BRS and heart-rate 
variability (SDNN: standard deviation 
of normal-to-normal beats) in the 
resting supine position and after 
standing up in patients with long-
standing insulin-dependent diabetes 
meliitus (IDDM) with autonomic and 
sensory neuropathy. 
We enrolled 12 patients (six 
women, six men, mean age 47-8 (SD 
15-9] years, duration of I D D M 26-8 
[13-4] years, H b A l c 9 1 [1-4]%, 
body-mass index 26-1 [5-0]) and 12 
healthy controls with similar sex, age, 
and weight distributions. We excluded 
patients with coronary heart disease 
and those with any other disorders or 
on any medication likely to affect the 
investigated indices. Autonomic 
function was assessed by five standard 
cardiovascular reflex tests. A score 
(0-10) was used to express the severity 
of the autonomic impairment . 
Peripheral sensory nerve function was 
characterised by current perception 
thresholds measured by a neuro-
selective diagnostic stimulator on the 
peroneal and median nerves, which 
permits transcutaneous testing at three 
sinusoidal frequencies (2000, 250, and 
5 Hz) of electrical stimulus. We 
measured blood pressure continuously 
by means of a non-invasive photo-
plethysmographic device.' T h e 
continuous electrocardiogram signal 
was fed through an analogue-digital 
convener and the data were analysed 
off-line. 
BRS was calculated in the supine 
posi t ion and after standing up by 
spontaneous sequences method. We 
confirmed that three or more cardiac 
cycles of unidirectional increase or 
decrease in blood pressure, together 
with the corresponding lengthening or 
shonen ing of the intcrbeat intervals, 
form spontaneous up sequences or 
down sequences. These sequences are 
similar to those induced by drugs, and 
a s p o n t a n e o u s B R S could be 
determined as an average of several 
individual s lopes . All changes in 
systolic blood pressure were paired 
with the changes in the subsequent 
R R intervals (lagl technique). 
T h e mean au tonomic score of the 
I D D M patients was 5-7 [2-4] and all 
had raised c u r r e n t perception 
thresholds. In the I D D M group, BRS 
was lower in the resting supine 
position and after standing up than in 
the con t ro l s ( tab le) . S D N N was 
depressed in the I D D M patients 
compared with the controls. In the 
control group, BRS was lower after 
s t and ing u p than in the resting 
position. In the I D D M group, there 
was no significant difference in the 
BRS values measured in the supine or 
s tanding positions. T h u s , the I D D M 
pa t i en t s wi th polyneuropathy 
displayed a severely impaired cardio-
vascular adaptat ion mechanism. The 
decreases in hear t -rate variability and 
BRS probably contr ibute to the poor 
p rognos i s of acu te myocardial 
in fa rc t ion in d iabe t ic patients. 
Sc reen ing for an autonomic 
dysfunction in diabetics could identify 
patients at increased risk of cardiac 
death. 
»Csaba Lengyel, Tamás Törők, 
Tamás Várkonyi, Péter Kempler, 
László Rudas 
' F i r s t Department of Medicine and Medical 
Intensive Care Unit. Albert Szent-Györgyi 
Medical University. H-6701 Szeged. FOB 
4 6 9 . Hungary: and First Department of 
Medicine. Semmelweis University. Budapest 
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Mortara A, Schwartz PJ, for the ATRAM1 
Investigators. Barorefiex sensitivity and 
heart-rate variability in prediction of toul 
cardiac mortality after myocardial 
infarction. Lancci 1996; 351: 478-84. 
2 Ewing DJ, Campbel l I V , Clarke BF. The 
natural history of diabetic autonomic 
neuropathy. QJMed 1980; 49: 95-108. 
3 Ziegler D . Diabetic cardiovascular 
autonomic neuropathy: prognosis, 
diagnosis and t reatment . Diabetes Metab 
Rev 1994; 10: 339-83 . 
4 Abbud ZA, Shindler D M , Wilson AC, ct 
al. Effect of diabetes meliitus on short- and 
long-tenn mortality rates of patients with 
acute myocardial infarction: a statewide 
study. Myocadial Infarct ion Data 
Acquisition System Study Group . 
Am Heart J 1995; 130: 51 -58 . 
Isolation of measles virus 
from infants in Lusaka 
Sir—N S Wairagkar and colleague! 
(Feb 14, p 495) ' confirm measle« 
infections in infanis younger than 4 
months in India by isolation of measles 
virus. Since 1992, we have been 
isolating measles virus from children 
admitted to hospital in Lusaka, Zambia. 
Between 1992 and 1995, 1670 children 
in the paediatric ward of the University-
Teaching Hospital had a clinical 
diagnosis of measles. 39S (23 8%) 
children were younger than 9 months, 
the recommended age of measles 
vaccination in Zambia, 192 (11-2%) 
were aged 6 months or less, ana 44 
(2-6%) were 4 months or less. 
Isolation of measles virus was carried 
out by throat swabs and peripheral-
blood mononuclear cells by B95-a cells 
which are highly sensitive for isolation 
of clinical measles strains.' We also 
tested serum samples for measles-
specific IgM antibodies by ELISA.-' One 
of nine throat swab samples collected 
from infants aged 4 months was positive 
for the virus isolation, and six scams 
each were isolated from infants aged 5 
and 6 months. IgM antibodies were 
detected in two of four cases aged 4 
months, and all samples from those 
aged 5 or 6 months were postitive. Tne 
low rate of virus isolation might reflect 
the delay of the sample collection after 
the onset of clinical symptoms. 
Measles infection before the 
recommended vaccination age is an 
important issue for measles control in 
developing countries. ' In Lusaka, 
measles infection in infants younger 
than 6 months is still common, and our 
laboratory results also confirmed 
measles infections in this age-group. 
Since measles vaccinadon with high 
litre vaccines is no longer 
recommended,' an alternariv-e strategy-
should be urgently established to 
protect infants and young children in 
developing countries. 
*Hitoshi Oshitani, Mwila E Mpabalwani. 
Hiroshl Suzuki 
•Department of Public Healtn, Niigata 
University School of Medicine 1-757 
Asahimachi-dori Niigata City. 951-8510. Japan; 
and Virology laboratory, University Teaching 
Hospital, Lusaka. Zambia 
(e-mail: oshitani@med.niigata-u.ac.jp) 
' 1 Wairagkar NS, Shaikh NJ, Udavant P, 
Banerjec K. Isolation of measles virus below 
4 months of age during an outbreak in Punc, 
India. Lancet 1998; 351: 495-96. 
2 Oshitani H, Suzuki H, Mpabalwani M , et a!. 
Laboratory diagnosis of acute measles 
infections in hospitalized children in 
Zambia. Trop Mat b Jni Health 1997; 2: 
612-16. 
3 Kobune F, Sakata H, Sugiura A. Marmoset 
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Windowed l:I'l' dinino the head-iiji tilt test J Clin Basic Cardiol 1999; 2: 241 
Windowed FFT - a time-variant spectra! analysis: 
applicability during the head-up tilt test 
T. Szili-Török1, Z. GingP, A. Kardos3, L. Halmai1 , L. Rudas1 
The spectral assessment of heart rate variability (HRV) and blood pressure variability (BPV) is a well-established method for 
the identification of rhythmic fluctuations during stationary conditions, but there is no generally accepted method of describing 
dynamic changes in such spectral patterns. Our goal was to introduce an alternative means of assessing the dynamics of spectral 
HRV 
Continuous ECG and non-invasive BP recordings on 29 subjects during head-up tilt testing were subjected to analysis. The 
total spectral power and the power over the low (LF: 0.04-0.15 Hz) and the high-frequency (HF: 0.15-0.4 Hz) spectral bands 
were recalculated in an overlapping series with constant time shifting of the initial data-point. 
The time course of LFHRV augmentation, with an early peak and subsequent levelling within the first 2 of tilting, was also 
documented, with parallel changes in LFBPV (LFHRV ms2/Hz: 290 ± 96 supine, 2707 ± 1557 maximum after tilt, p < 0.05 
LFBPV mmHg-VHz: 10 ± 4 supine, 58 ± 26 maximum after tilt, p < 0.05). In a subgroup of 7 patients who exhibited syncope 
upon tilting, a statistically significant early increase HFHRV was also detected, followed by significant decline by the second 
minute of tilting (HFHRV ms2/IIz: 143 ± 80 supine, 1054 ± 902 maximum after tilt, 125 ± 84 minimum after tilt). This early 
HFHRV peak was absent in the group of tilt-negative subjects. Another characteristic feature of the tilt positive group was a 
second phase of LFBPV and LFHRV elevation preceding the syncopal episode. 
Windowed fast Fourier transformation is a suitable method for assessment of dynamic HR and BP spectral changes during 
upright tilt testing. The method is well applicable for the analysis of tilting-induced autonomic responses./ Clin Basic Cardiol 
1999; 2:241-4. 
Keywords: spectral analysis, heart rate variability head up tilt 
Modulation of cardiac interbeat intervals has been sub-jected to extensive studies. A certain degree of consen-
sus regarding the spectral assessment of the heart rate vari-
ability (HRV) has already been reached [1, 2]. When fast 
Fourier transformation (FFT) is used to assess HRV, a mini-
mum period of 2-3 mins is required [1,2], This is somewhat 
of a paradox: during 2 mins of a manoeuvre in which the au-
tonomic tone can change, the significant changes in autonomic 
tone are completed. Thus, the spectral approach focuses on 
discrete sections of the events and there is no appropriate tool 
to characterize the dynamics of the spectral fluctuations. A 
new time-dependent analysis, based on the autoregressive 
method, was recently reported [3]. Our present goal was to 
introduce an alternative means of assessing the dynamics of 
the spectral HRV and blood pressure variability (BPV). As 
head-up tilt testing (HUT) results in characteristic changes 
in the cardiovascular autonomic tone, we tested the applica-
bility of our suggested method, windowed FFT, by analysing 
the records on 29 subjects during HUT. Since the literature 
data relating to the modification of HRV and BPV during 
H U T are controversial, a further goal was to describe the HRV 
and BPV changes during H U T with this novel method, fo-
cusing on the dynamics of the changes. 
Methods 
Patient population 
Records on 29 patients during H U T were selected from our 
data base. All subjects had been referred to the arrhythmia 
service because of unexplained syncope. During the initial 
assessment, including history, physical examination, ECG and 
echocardiography, a cardiac cause of the syncope was defi-
nitely excluded in each case. Only virtually noise-free records 
were considered for further analysis. Records with ectopic 
beats were also excluded from the study. 
Head-up tilt test 
The tilt-table test was performed in a quiet room with low 
light and always between 10 and 12 a.m. After 30 min in a 
supine resting position, patients were tilted to 70° for 40 min. 
A table with a footboard support was utilised, and the tilt po-
sition was reached in 30 s. Baseline ECG and BP recordings 
were made for 10 min prior to tilting, and were continued 
throughout the study. Syncope was defined as a transient loss 
of consciousness, accompanied by a loss of postural tone. 
Warning symptoms of syncope include nausea, vomiting, im-
paired vision, the hearing of distant sounds, a slow response 
to verbal commands, and a partial loss of postural tone. Dizzi-
ness accompanied by one or more of the above symptoms 
was defined as presyncope. 
Data acquisition and analysis 
BP was monitored with a photoplethysmograph (Finapres 
2300, Ohmeda). ECG signals were recorded by a 5-lead sys-
tem. The BP and ECG signals were transmitted through an 
amplifier, filter and analogue-digital converter into an IBM-
AT-compatible computer. Data were stored and analysed 
off-line by means of a program developed in our laboratory. 
With our system the precision of RR interval detection is 2 
ms, and that of BP detection is 1 mniHg. Power spectrum 
analysis was performed on 2-min segments of the ECG and 
BP records by using FFT over two frequency bands. The 
low-frequency band (LF) of the HRV and systolic BPV was 
defined at 0.04—0.15 Hz, and the high-frequency component 
(HF) at 0.15-0.4 Hz [4], 
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W i n d o w e d F F T 
Windowed F F T is a na r row t ime Fourier transformation. 
Briefly, the method is based on recalculation of the FFT with 
a variable shift ing of the initial complexes in time, allowing 
the generation o f 3 D representat ions of spectral changes. The 
principles of the mathematical assessment were formulated 
by Gabor in 1946 [5J; the cor responding equation is: 
X(f.T) = Jw(t.T)x(t)e-'2 , t f tdt 
where x(t) is the signal to be t ransformed. w(t,T) is the win-
dow function, T is the t ime variable for the t ime-dependent 
spectrum X(f.x). 
For w(t) , the H a m m i n g w i n d o w is used with 2 -min 
durations. F F T was pe r fo rmed to calculate the power spec-
t rum for all f requencies for this t ime range. Shifting the win-
dow in time yields the t ime-dependent power spectrum. In 
this study, the me thod was applied for both the RR interval 
and BP records. T h e t ime course o f H R and systolic BP spec-
tral changes was analysed in each case, and power spectrum 
values of certain characteristic tilt stages were determined. 
Values calculated f rom the last sequence prior to tilting were 
defined as baseline. Post-tilt m a x i m u m and m i n i m u m values 
in the LF and FIF power bands for both H R and systolic BP 
were determined and compared with the baseline. For those 
exhibiting syncope, the corresponding values were also deter-
mined at the t ime of fainting. 
noeuvre was mainly due to an LFBPV in both groups (Tables 
2 and 3). Subsequently, T F B P V a n d LFBPV decreased in both 
groups and levelled at lower - than-maximum values for sev-
eral minutes. Nevertheless, the m i n i m u m TFBPVand LFBPV 
values after tilting in this phase remained significantly higher 
than the baseline in the tilt-negative group (Table 2). The same 
tendency was seen in the tilt-positive group, but the differ-
ence in m i n i m u m T F B P V a n d LFBPV did not reach statisti-
cal s ignificance as compared with the baseline (Table 3). 
TFI1RV and LFHRV increased significantly in response to 
tilting, and then declined quickly to post-tilt m in imum val-
ues, but these were still significantly higher than the baseline 
in both groups. Peaking occurred within the first minute after 
the complet ion of tilting. A different response was seen when 
11FHRV was assessed. In the tilt-negative group, H F H R V 
decreased immediately on tilting and underwent no subse-
quent changes, whereas a significant increase in this param-
eter was seen in the tilt-positive group. This increase reached 
its peak within 60 s after tilting, and H F H R V then quickly 
returned to a lower-than-baseline level (Table 3). The syncopal 
episode itself in the tilt-positive group was characterised by a 
d iminut ion of all H R V spectral bands, though this decline 
reached statistical significance for only the T F H R V and 
LFHRV bands as compared with the baseline. There was a 
similarly marked reduction in the T F B P V a n d LFBPV com-
ponents in association with syncope. In contrast, the HFBPV 
componen t displayed a small and statistically non-significant 
increase (Table 3). 
S t a t i s t i c a l ana lys i s 
Changes were compared wi th the baseline by using ANOVA 
for repeated measures . For parameters exhibit ing a non -
Gaussian distribution, the Friedman one-way repeated meas-
ures ANOVA on ranks was used. T h e level of statistical sig-
nificance was set at p < 0.05. 
Results 
Twenty-two subjects exhibited no abnormal reactions during 
the tilt test (tilt-negative cases). Syncope developed in 7 sub-
jects (tilt-positive cases), 7 to 30 min after tilting. The tilt-
positive subjects displayed a "mixed response", characterised 
by bradycardia and a variable degree of hypotension. Demo-
graphic data on the tilt-positive subjects are shown in Table 1. 
T h e mean ages of the tilt-positive and negative subjects were 
similar (22.1 ± 4.4 and 23.5 ± 3.7 years, respectively; 
P = NS) . 
U p o n tilting, there were immediate fluctuations in HR and 
systolic BP power spectral componen t s (Figures 1 and 2). A 
statistically significant increase in the total-frequency systolic 
BPV (TFBPV) wi th in 2 m i n f r o m the beginning of the ina-
Table 1. Demographic and tilt-table test data on patients with 
positive tilt-table test 
Pt. no. Age 
(yr) 
Gender Time of syncope 
from tilting (min) 
dSBP 
(mmHg) 
dHR 
(l/min) 
1 22 F 8 135 85 
2 30 F 7 50 59 
3 18 M 10 72 39 
4 22 M 8 95 41 
5 24 F 10 47 43 
6 23 F 6 62 41 
7 16 F 30 68 52 
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Figure 1. Upright tilt-induced responses of a patient from the 
tilt-negative group. Panel A. Normal heart rate response to upright 
tilt. The postural change at 600 s of the recording is accompanied 
by a certain RR interval shortening. Panel B. Although the fluctua-
tions in systolic BP are augmented following the upright tilt, no 
clinically significant hypotension is recorded. Panels C and D. 
Variations in HR (C) and systolic BP (D) powers with time, as as-
sessed by the windowed FFT method. Solid lines indicate total 
power, dashed lines indicate LF power, and dotted lines indicate 
HF power The upright tilt manoeuvre elicits transient elevations in 
the LFHRV and TFHRV power. The BP power reveal immediate 
tilt-related increases in the same spectral bands, followed by sub-
sequent fluctuations of lesser magnitude. The terminal increases in 
the BPV components are related to the motion artefacts at the time 
of termination of tilting. 
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Discussion 
T h e assessment of H R V by spectral analysis is gaining increas-
ing use in clinical cardiology [1 .2] . However, the method of 
spectra] analysis dissects the series of events into discrete se-
quences. allowing no overlap in the assessment. Only a few 
publications related to t ime-dependent spectral assessment [3. 
6], but the proposed methods are not yet widely accepted. 
Thus , spectral analysis currently remains the best possibility 
for the description of stationary states. Dynamic changes are 
usually expressed as differences between two stable conditions, 
wi thou t any analysis of the process of transition between the 
two states. T h e effect of upright tilting on HRV is typically 
characterised by comparing the supine resting condition with 
that in a given post-tilt period. Tiiis post-tilt transient is de-
fined either in a given time interval after the beginning of or 
prior to termination of the tilt manoeuvre [7-9] , or at a fixed 
t ime preceding the syncopal event [ 10]. O u r results indicate 
complex fluctuations in the HRV and BPV spectral param-
eters upon tilting. T h e major f inding in this study is that 
LFHRV and LFBPV increase markedly and promptly after the 
tilt position is reached. If F F T is used this effect can not be 
observed, because it occurs in the first 30 s of the post-tilt 
period. At the time of presyncope, when the sympathetic tone 
is declining, these components are greatly decreased. Station-
ary analysis would yield a quite different spectrum in an early 
assessment starting wi th the tilt procedure, as compared with 
a delayed analysis performed even only 2 min post-tilting. O u r 
observations suggest that certain discrepancies in the litera-
ture tilt test results might have been due to the different tim-
ings of the assessment. Tlieodorakis et al. generated a series of 
adjoining spectral segments to characterise the tilt-induced 
responses 11 1 ], and presented first documented t ime-depend-
ent spectral fluctuations. Pagani et al. selected "stationary sec-
tions ofdata botli at rest and dur ing tilting" for assessment; the 
exact t iming of their post-tilt data acquisition, however, was 
not reported [12], Mon tano et al. reported on a study in whicli 
they applied different extents of angle tilting for periods of 10 
min. From the cont inuous recordings, stationary segments 
devoid of arrhythmia [200 to 500 RR intervals] were analysed, 
but the t iming of data acquisition in relation to the onset of 
tilting was not stated [13]. Boulos et al. determined spectral 
changes by compar ing tiie baseline values witli those for the 
last 256 consecutive beats of a 15-min tilt test [9], Bootsma et 
al. reported on the effects of different angle tilting, but they 
excluded f rom their analysis the first minute of recordings in 
each position: min 2 to 5 were used for computat ion of HRV 
spectra [7], Mizumaki et al. established tilt-induced spectral 
responses by compar ing supine resting values with those re-
corded dur ing the last 200 beats until 1 min before the end of 
the tilt [ 10]. Bloomfield et al. performed comparisons between 
data acquired in a supine position and those recorded during 
the last 5 min of a 13-min tilting [8], In general, the investi-
gators tended to select artefact-free stationary segments of the 
recordings, thereby precluding assessment of the phase of the 
postural change itself. Most of the cited reports indicated a 
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Figure 2. Typical t i l t- induced responses of a tilt-positive patient. 
Panel A. The RR interval tachogram. The tilting, indicated by a 
vertical line is reflected by an immediate HR acceleration. The 
sudden-onset bradycardia after 800 s of the recording coincides 
with the syncopal episode. Panel B. The systolic BP trend curve 
reveals transient stabil isation post-tilting, fol lowed by a marked 
hypotension, eventually leading syncope. Panels C and D. Varia-
t ions in HR (C) and systolic BP (D) with time, as assessed by 
w indowed FFT in the same arrangement as in Figure 1. The upright 
tilt manoeuvre is paralleled by elevations in the LFHRV and TFHRV 
powers. The duration of the elevations in these frequency ranges is 
pro longed, however, relative to the normal, and they are interrupted 
by further peakings. The subsequent decreases in the spectral 
components precede the syncopal episode. 
Table 2. Changes in spectral components during head-up tilt test 
in the ti lt-negative group (n = 22) 
Supine 
position 
Maximum 
after tilt 
Minimum 
after tilt 
TFHRV (ms2/Hz) 1 2 5 5 + 3 9 2 3 8 3 5 ± 1 8 9 2 * 1 6 1 8 ± 4 1 5 * 
LFHRV (ms2/Hz) 5 1 4 + 1 6 3 2 3 0 0 ± 9 7 7 * 8 8 8 ± 2 2 3 * 
HFHRV (ms2/Hz) 5 5 7 ± 2 3 4 2 8 9 + 9 4 N S 2 4 7 + 9 7 N S 
TFBPV (mmHg2 /Hz) 1 2 ± 3 1 1 0 1 2 8 * 3 8 ± 10* 
LFBPV (mmHg2 /Hz) 5 + 1 5 4 + 1 1 " 2 2 ± 5 " 
HFBPV (mmHg2 /Hz) 1 + 0 4 ± •]NS 2 ± 0 N S 
TFHRV: total-frequency heart rate variability, LFHRV: low-frequency 
heart rate variability, HFHRV: high-frequency heart rate variability, 
TFBPV: total-frequency b lood pressure variability, LFBPV: low-
frequency b lood pressure variability, HFBPV: high-frequency blood 
pressure variability; * p < 0.05 vs. supine position, NS non-significant 
Table 3. Changes in spectral components dur ing head-up tilt test 
in the ti lt-positive g roup (n = 7) 
Supine Maximum Minimum During 
position after tilt after tilt syncope 
TFHRV 673± 202 4379± 2064* 10721670* 2431105* 
(ms2/Hz) 
LFHRV 290± 96 2707± 1557* 663 1 394* 92131* 
(ms2/Hz) 
38+ 28 n s HFHRV 143± 80 1054± 902* 1251 84NS 
(ms2/HZ) 
TFBPV 24+9 86± 33* 371 21NS 17+6* 
(mmHg2/Hz) 
23114 N S LFBPV 1Q+4 58± 26* 210* 
(mmHg2/Hz) 
HFBPV 24± 0 2 ± 0 N S 3 1 1 N S 4 1 2 n s 
(mmHg2/Hz) 
TFHRV: total-frequency heart rate variability, LFHRV: low-frequency 
heart rate variability, HFHRV: high-frequency heart rate variability, 
TFBPV: total-frequency blood pressure variability. LFBPV: low-
frequency b lood pressure variability. HFBPV: high-frequency blood 
pressure variability; * p < 0.005 vs. supine position, N S non significant 
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Figure 3. 3D project ion of the HRV (upper panel) and BPV (lower 
panel) spectral changes fol lowing the upright tilt as assessed by 
windowed FFT in the same syncopal patients as in Fig. 2. The spatial 
project ion allows a thorough assessment of the temporal changes 
and interrelationship of all spectral components. Thus, it is apparent 
that the double elevation in the LFBPV response depicted in Fig. 2 
is related to changes in different segments of the LF band. Even 
the two minor elevations in the HFBPV band are quite discernible. 
tilt-induced increase in LFHRV, with an increased ratio LFHRV/ 
H F H R V [8-10] . O u r f indings are in general agreement with 
those of previous studies, bu t we found that these changes are 
most p ronounced wi th in the first 2 min post-tilting. Never-
theless, the subsequent equil ibr ium, which is basically main-
tained until the end of tilting in tilt-negative subjects, is still 
characterised by a predominance of LFHRV markers. 
T h e c o n t i n u o u s assessment allowed us to detect a 
short-last ing increase in H F H R V among tilt-positive subjects 
very early after tilting. This temporary increment in H F H R V 
among syncope subjects is strikingly different f rom the im-
media te H F H R V d i m i n u t i o n detected in the group ot 
tilt-negative patients, and may indicate parallel changes in the 
vagal regulation. Some of the previous studies demonstrated 
an increased H F H R V jus t prior to an episode of syncope [9, 
11], but no early post-tilt peak of H F H R V has been reported 
previously. T h e significance of this finding is not clear and 
demands fu r ther studies. D u r i n g the phase of equil ibrium, 
ie, after the first 2 min. of tilting, no apparent differences in 
spectral t rends were seen between the two groups. T h e spec-
tral constellation among negative subjects remained unchanged 
until the end of the study (Figure 1). In contrast, a second 
phase of LFI IRVand HFI1RV elevation was seen among tilt-
positive subjects prior to syncope (Figures 2 and 3). I lowever, 
the magni tude of these peaks did not attain the level of the 
initial increments. Since our program predicted determinations 
of only one m i n i m u m and maximum value for each subject, 
these presyncopal peaks in the tilt-positive group remained 
numerical ly uncharacter ized. Nevertheless , similar pre-
syncopal increments in U H R V h a v e been repeatedly reported 
[11, 14]. T h e LFHRV component presumably represents sym-
pathetic activation; indeed, studies on presyncopal catechol-
amine levels [15] and muscle sympathetic nerve activity re-
cordings documented transient pre-syncopal elevations [16, 
17], T h e mechanism of presyncopal elevation in H F H R V is 
not clear. T h e increase may represent the intense vagal st imu-
lation preceding the onset of syncope [9], However, we have 
observed a presyncopal increase in HFBPV as well (Figures 2 
and 3), a phenomenon difficult to explain in terms of any va-
gal mechanism. We hypothesize that this H F B P V peak is a 
consequence of the presyncopal decrease in venous return, 
which results in central hypovolaemia and in increased breath-
ing-related fluctuations in the stroke volume. T h e increased 
I IFBPV may in turn contr ibute to the genesis of the H F H R V 
peak via baroreflex mechanisms. O n e limitation of our study 
is that the magnitude and t iming of the presyncopal spectral 
peaks remained undefined. It is well known that the duration 
of presyncope varies widely in these patients. Thus , a station-
ary analysis in a fixed time interval prior to the full-blown 
syncope may be inadequate for a representat ion of the 
presyncopal constellations. Individual characterization of the 
presyncopal peaks would be desirable. 
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Abnormal cardiovascular autonomic regulation in 
Parkinson's disease 
T. Szili-Török1, L. Rudas1 . G. Dibó2 , D. Paprika1, A. Kardos3 
Parkinson's disease (PL")) is of ten associated with an autonomic neuropathy. T h e extent of autonomic involvement, however 
is poorly defined and unpredictable. In order to assess the autonomic cardiovascular regulation t ime and frequency domain 
indices of heart rate and f requency domain indices of blood pressure the variability was determined non-invasively in 20 
patients (age: 66 ± 8 years) wi th PD. T h e arbitrarily chosen level of spontaneous linear baroretlex sensitivity (BRS) of 3.5 ms/ 
m m H g served to divide P D patients into subgroups. 12 P D patients exhibited a normal (nBRS). and 8 an impaired (iBRS) BRS. 
T h e results were compared with those f rom 18 healthy age-matched volunteers. T h e group of iBRS P D patients exhibited 
marked abnormalit ies in the other indices of cardiovascular autonomic regulation. In contrast, nBRS P D patients displayed 
only modest deviations. It is concluded that a decreased BRS is a distinctive feature of the impaired cardiovascular autonomic 
regulation in this heterogeneous population, and may serve as a selection marker for fur ther assessment. J Clin Basic Cardiol 
1999; 2: 245-1. 
Key w o r d s : Parkinson's disease, baroreflex sensitivity 
It is well documen ted that Parkinson's disease may be associ-ated with a dysfunct ion of the autonomic nervous system. 
In idiopathic Parkinson's disease, this dysfunction can be ex-
plained by damage to neurological structures. Histological 
studies have proven the presence of Lewi's bodies in sympa-
thetic and parasympathetic preganglionary neurons and also 
in central s tructures associated wi th the autonomic regula-
tion [1]. To characterize the cardiovascular autonomic regu-
lation, reflex tests of various complexity, such as the Valsalva 
maneuver or active orthostasis were traditionally used. These 
tests were of ten carried out in panels as a test series [2, 3], A 
wel l -known example is the Ewing Panel [4], In recent years, 
several studies have been reported in which Parkinson's dis-
ease patients were tested by this method . [5-15]. These tests 
require an active participation of the patients, and thus the 
hypokinesis, rigidity and t remor characteristic of Parkinson's 
disease led to serious limitations. It is obvious that with some 
patients these tests are infeasible or the results are meaning-
less. T h e measurement of au tonomic parameters using power 
spectrum analysis of heart rate (HR) and blood pressure (BP) 
and a non-invasive de te rmina t ion of baroreflex sensitivity 
(BRS) does not require the active participation of patients. 
O n e aim of the present study was to determine the mark-
ers of heart rate and blood pressure variability (HRVand BPV) 
in Parkinson's disease. A fur ther goal was to verify our pre-
sumpt ion that the pathological BRS level separates the disor-
dered au tonomic regulation and autonomically intact sub-
groups of Parkinson's disease patients. 
Methods 
P a t i e n t p o p u l a t i o n 
T h e study involved 20 patients wi th Parkinson's disease w h o 
were recruited t rom the Parkinson's Outpat ient Clinic of the 
Neurological Depar tment at Albert Szent-Györgyi Medical 
University. Patients wi thout history of any cardiovascular dis-
ease, and wi th negative physical examinat ion and normal 
12-lead E C G were selected for this study. Neurological char-
acteristics of the patients are shown in Table 1. T h e average 
age was 6 6 + 7 years. T h e average age at the t ime of the diag-
nosis was 60 ± 8 years. T h e duration of the Parkinsonian signs 
was on average 71 ± 62 months. 76 % of the patients were on 
L-DOPA, 63 % on a M A O inhibitor, 25 % on an anticholin-
ergic drug. 67 % on amantadine and 31 % on bromocryptine. 
3 6 % of the patients took antidepressants and 1 5 % beta-
blockers. All measurements were conducted in the af ternoon, 
4 - 5 hours following the last meal. T h e participants were re-
quested to avoid smoking and to refrain f rom caffeine-con-
taining beverages for 6 hours prior to the examinations. The 
subjects were equipped wi th the peripheral unit of the Penaz 
system non-invasive BP monitor (Finapres 2300) and ECG 
electrodes. C o n t i n u o u s BP and H R measuremen t s were 
started after a 10-rnin resting period. BP and H R were moni -
tored and recorded in a supine position for 20 mins. Data were 
analysed off-line. By means of the 3.5 m s / m m H g limit the 
Parkinson's disease patients were divided into two subgroups: 
those with a normal BRS (nBRS; 12 patients) and those with 
an impaired BRS (iBRS; 8 patients). Most of the previous stud-
ies utilized pharmacological (phenylephrine) BRS tests. It has 
been documented that phenylephrine and spontaneous BRS 
values are closely related but not interchangeable [16], There-
fore we selected our cut off point at 3.5 m s / m m H g . 
Table 1. Clinical characteristics and neurodiagnostic test scores of 
subjects 
Control PD nBRS PD iBRS 
N = 18 N = 12 N = 8 
Age (years) 65 ± 9 64 ± 6 67 ± 7 
Sex (M/F) 9/9 6/6 3/5 
Age at onset of 
disease (years) - 60 ± 7 59 ± 8 
MMSE score 29 ± 0.9 27.3 ± 0.7 27.8 ± 0.6 
UPDRS - 26.5 ± 0.3 25.9 ± 0.4 
HY - 2.0 ± 0.1 2.1 ± 0.1 
Data are mean ± SD; PD = Parkinson's disease with normal BRS 
(nBRS) and with impaired BRS (iBRS); M = male. F = female. 
MMSE = Mini Mental State Examination; UPDRS = Unif ied 
Parkinson's Disease Rating Scale; HY = Modif ied Hoehn and Yahr 
staging 
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Measurements and calculations 
The EGG was continuously recorded with a Sirecust 730 (Sie-
mens) monitor. Blood pressure was measured non-invasivelv 
with a Finaprcs 2300 (Ohrneda) device, which reliably reflects 
blood pressure spectral changes. The Pcnaz system photo-
plethysmographic finger blood pressure monitor reconstructs 
a continuous blood pressure curve that closely follows the 
invasively recorded blood pressure fluctuations. The R wave 
of the EGG and the plethysmographic signals were fed through 
an amplifier, filter and analog-digital converter into an IBM-
AT-compatible computer. The computer measured the inter-
val between successive R waves with a precision of 2 ms. The 
accuracy of ECG signal detection was 40 microvolts and 
1 mmHg of the blood pressure measurement. The cardio-
tachogram and trend-grams of the BP values were continu-
ously recorded on-line. Spectral analysis of the R-R interval 
and systolic HPV was performed by fast Fourier transforma-
tion. using the Hamming window over two frequency bands: 
low-frequency power (0.04 to 0.14 Hz) and high-frequency 
power (0.15 to 0.4 Hz). The total frequency power range from 
0.01 to 0.4 Hz was considered. The short-term measures of 
time domain indices as the average normal R-R intervals (mean 
R-R), SDNN, pNN50, rMSSD were also calculated. BRS 
was characterized by the spontaneous sequences method as 
described earlier [17, 18). It has been established that 3 or 
more cardiac cycles of unidirectional BP increase or decrease 
with the corresponding lengthening or shortening of the 
interbeat intervals to form spontaneous ''up-" or "down-se-
quences". These sequences are analogous to those induced 
by pharmacological maneuvers, and a spontaneous BRS could 
be determined as an average of several individual slopes. In 
this study, all of the changes in systolic blood pressure (delta 
SBP) were paired with the changes in the subsequent RR in-
tervals (delta RR). This method is referred to as the lagl tech-
nique [17, 18). 
Statistical analysis 
HRV, BPVand BRS values of patients with Parkinson's dis-
ease showed non-gaussian distribution. These data were ana-
lysed using the Friedman test. An a level of p < 0.05 was 
considered to be significant. 
Results (Table 2) 
The average RR interval length was shorter in both Parkin-
son's disease groups than in the healthy volunteers. The 
systolic blood pressure, however, was very similar in all three 
groups. rMSSD was almost the same in the control group and 
the nBRS group. In the iBRS group, the rMSSD was signifi-
cantly lower than in the other two groups. There was an even 
more marked difference in pNN50: the values for the healthy 
volunteers and the nBRS group were very similar, while that 
in the iBRS group was 0. There was a similar tendency in the 
spectral parameters of heart rate variability. TFI IRV, LFHRV 
and HFHRV for the nBRS group were all slightly below those 
for the healthy volunteers, whereas statistically significant dif-
ferences were observed between the iBRS group and the 
healthy volunteer group. The spectral markers of systolic blood 
pressure variability behaved differently from the other param-
eters. TFBPV and LFBPV for the iBRS group were signifi-
cantly higher than those for the control group. 
Discussion 
Parkinson s disease is a clinical diagnosis. Pathological exami-
nations reveal another syndrome, multiple systemic atrophy 
(MSA) in one-fourth of patients diagnosed as having Parkin-
son's disease. The extent and frequency of autonomic involve-
ment differ in the two syndromes [15]. It is even more im-
portant that the prognosis and the effect of the applied 
anti-Parkinson drugs also differ in the two entities, and their 
differentiation remains an important task for the future [6. 
19]. Bordet etal. consider that, because of the difficulties with 
traditional reflex tests, spectral analysis of heart rate variabil-
ity may be used even more widely to study the autonomic 
regulation in Parkinsonian patients in the future [6]. Frontoni 
et al. have already applied spectral analysis for the same rea-
sons in studies of multiple sclerosis [20]. To the best of our 
knowledge, this is the first publication relating to a spectral 
analysis of the HRV and BRS test in patients with Parkinson's 
disease. The MR spectrum is divided into "high-" and "low"-
frequency bands at a commonly agreed value [21]. The high-
frequency band is equivalent to breathing arrhythmias and is 
generated mainly by parasympathetic modulation. The gen-
esis of the low-frequency range is influenced by both sympa-
thetic and parasympathetic nervous mechanisms. While this 
view is somewhat simplistic, it may be of significance that both 
frequency ranges were reduced by spectral analysis in the iBRS 
group, and thus both the sympathetic and the parasympathetic 
components could be assessed as pathological. Spectral analy-
sis of BPV has not been carried out on Parkinson's disease 
patients so far. Netten et al. have reported studies on Parkin-
son's disease patients in which the Finapres blood pressure 
monitor was used [11], but they targeted the examination of 
orthostasis tolerance and handgrip-induced vasoconstrictor 
response. It is of importance that only one of the 23 patients 
studied by Netten et al. had to be excluded because of hand 
tremor induced blood pressure artifacts. In our group of 20 
patients, we had no such difficulties at all. BRS in Parkinson's 
disease patients was first examined by Appenzeller and Goss. 
They used the blood pressure and heart rate response in the 
overshoot phase of the Valsalva maneuver to characterize BRS, 
and concluded that these BRS values were pathological in some 
Parkinson's disease patients [22]. Our study confirms this and 
demonstrates some more general aspects of this early obser-
vation. The time and frequency domain indices of HRV were 
Table 2. Comparison of spectral autonomic parameters and BRS 
values between control, PDn and PDi groups 
Control subjects PD nBRS PD iBRS 
N = 18 N = 12 N = 8 
BRS (ms/mmHg) 9.9 ± 4 9.65 ± 6 2.1 ± 1* 
Mean RR (ms) 855 ± 100 689 ± 140 697 ± 9' 
Mean SBP (mmHg) 126 ± 21 117 ± 17 117 ± 22 
SDNN (ms) 52.4 ± 4.6 49.1 ± 3.1 34.9 ± 2.9' 
rMSSD (ms) 27.7 ± 8 27.2 ± 22 11.4 ± 4' 
pNN50 (%) 8± 7 11 ± 18 0 ± 0 ' 
TFHRV(ms2/Hz) 847 ± 595 382 ± 662 85 ± 63' 
LFHRV (ms2/Hz) 187± 152 63 ± 51 28 ± 23' 
HFHRV (ms2/Hz) 463 ± 480 261 ± 586 28 ± 36' 
TFBPV (mmHg2/Hz) 18± 16 15 ± 13 34 ± 51' 
LFBPV (mm Hg2/Hz) 1 ± 2 7 ± 8' 8 ± 10' 
HFBPV (mm Hg2/Hz) 8 ± 8 2 ± 3" 7 ± 11 
Data are mean ± SD; * = p < 0.05 compared with control group; 
PD = Parkinson's disease with normal BRS (nBRS) and with 
impaired BRS (iBRS): BRS = baroreflex sensitivity; SBP = systolic 
blood pressure; rMSSD, pNN50, TFHRV, LFHRV. HFHRV, TFBPV 
LFBPV HFBPV: explanation in method section. 
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also pathological in the group of patients classified as iBRS. A 
somewhat controversial tendency could be observed in the 
spectral parameters of systolic BPV The function of HRV is 
commonly known to be to buffer changes in BR Accordingly, 
it is not surprising that the amplitude of BR surges increases 
with decreasing HR fluctuation [23]. The significance of the 
abnormalities in cardiovascular regulation among Rarkinson's 
disease patients is not yet fully known. It is possible that the 
dysbalance of the sympathetic and the parasympathetic tone is 
connected with the arrhythmias developing in the ischaemic 
heart muscles. The pathological BRS that signalled an auto-
nomic dysbalance in the acute phase of myocardial infarction 
was a sensitive predictor of ventricular arrhythmias and sud-
den death [18], The connection between autonomic 
dysrcgulation and arrhythmia-related death has recently been 
considered in other, non-cardiovascular diseases, such as de-
pression [24]. Analogously, we can presume a connection be-
tween the autonomic dysbalance and the high mortality among 
Parkinson's disease patients [25, 26]. The mortality of Par-
kinson's disease patients is almost twice that for age and 
sex-matched healthy control groups [25]. The 20-year 
follow-up study by Ben-Shlomo and Marmot suggested that 
this increased mortality is connected with an increase in heart 
ischaemia-related deaths [26]. That study, however, did not 
distinguish sudden cardiac deaths, and thus the real impor-
tance of arrhythmia-related deaths could not be assessed. 
However, the available data indicate that a wide-ranging pro-
spective examination of autonomic regulation in Parkinson's 
disease patients would be justified. The examination of spon-
taneous BRS involves a non-invasive procedure that does not 
need the active cooperation of the patients and it can there-
fore be used with disabled or weak patients, too. Our results 
demonstrate that the procedure is quite suitable for screening 
autonomic involvement among Parkinson's disease patients. 
The predictive nature of the pathological BRS in this group 
necessitates further investigations. 
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Abstract 
Objective—Signs of a parasympathetic 
dysfunction have been revealed in pri-
mary Sjogren's syndrome (SS). Its role in 
the pathogenesis and the clinical picture 
of the disease is not clear. To investigate 
the responsiveness of SS patients to a 
cholinergic agonist, a model was used 
involving examination of the cutaneous 
microcirculation. The microvascular re-
sponse to the administration of carbachol 
was measured, a muscarinic cholinergic 
agonist. 
Methods—Twenty two SS patients and 12 
controls were examined. Carbachol and 
0.9% saline solution were administered 
intracutaneously into the forearm skin at 
two distinct places. Skin blood flow (SBF) 
in the injected areas was measured con-
tinuously before and for 10 minutes after 
the injections by means of a laser Doppler 
perfusion monitor. The increase in SBF in 
response to carbachol (dSBF), reflecting 
vasodilatation, was calculated by a for-
mula including the baseline and the maxi-
m u m SBF values after the injections of 
carbachol and saline solution. 
Results—The vasodilatation was signifi-
cantly lower in S S patients than in the 
controls (mean dSBF: 2.1 (range: 1.0-4.5) 
versus 3.3 (range: 1.7-7.6), p=0.02). With 
non-responder patients defined as those 
in whom a smaller response was observed 
than in any of the controls, 11 of the 22 SS 
patients proved to be non-responders to 
carbachol. Comparisons of demographic, 
clinical and laboratory characteristics 
and HLA class II genotypes between 
responder and non-responder SS patients 
did not show any significant differences. 
Conclusions—A diminished or absent re-
sponse to carbachol indicates a choliner-
gic dysfunction in SS patients. A 
disturbance in the neurotransmission at a 
receptorial or postreceptorial level is 
hypothesised. Unresponsiveness to 
cholinergic stimuli may contribute to exo-
crine insufficiency. 
CAnn Rheum Dis 2000;59:48-53) 
Dry mouth and dry eyes, the two fundamental 
symptoms of primary Sjogren's syndrome 
(SS), have previously been regarded solely as 
direct consequences of the loss of functioning 
glandular tissue caused by an autoimmune 
inflammatory process. However, this concep-
tion is now increasingly questioned.12 The 
symptoms of dryness and the quantitatively 
determined saliva and tear production may 
vary greatly during the course of the disease, 
even without treatment, and their spontaneous 
improvement is often observed for varying 
periods. A marked discrepancy has been 
reported between the degree of exocrine insuf-
ficiency and the histologically verified intensity 
of the inflammatory infiltration in the salivary 
glands.3 In human and animal experiments, 
several types of abnormalities of the autonomic 
nervous system have been demonstrated in 
SS."10 
The question of whether an impairment of 
parasympathetic innervation may play a part in 
the elicitation of exocrine insufficiency in SS 
remains an issue to be examined. Despite pre-
vious work, results of human functional studies 
on the parasympathetic nervous system in SS 
patients are by no means numerous. If a postu-
lated cholinergic dysfunction does exist, it is 
not known whether it is caused by a central or 
a peripheral nervous system dysfunction, or 
whether it reflects a disorder of the parasympa-
thetic innervation at a receptorial or postrecep-
torial level. Nor is it clear whether the 
acetylcholine transmitter system or a non-
adrenergic, non-cholinergic transmitter (for 
example, vasoactive intestinal polypeptide 
(VIP)) system colocalised in the cholinergic 
nerve terminals is involved." 
For these reasons, we set out to examine the 
response to the administration of a muscarinic 
cholinergic agonist, carbachol, in SS patients 
and to compare it with that in healthy controls. 
To measure this response, we established a 
model involving examination of the cutaneous 
microcirculation. A cholinergic vasodilatory 
mechanism of the human skin blood vessels has 
long been verified.12"''' As this is similar in many 
respects to the cholinergic innervation of the 
salivary glands,13 we decided to use this experi-
mental setting to test the hypothesis that a 
cholinergic dysfunction exists in SS patients. 
Methods 
PATIENTS AND CONTROLS 
Twenty two primary SS patients (20 female 
and 2 male) were enrolled in the study. All were 
diagnosed as having SS by the European Com-
munity criteria" at the Division of Autoim-
mune Diseases at the 1 st Department of Inter-
nal Medicine, Albert Szent-Györgyi Medical 
University, Szeged, Hungary. The average age 
of the patients was (mean (SD)) 50.6 (13.2) 
years (33-60). The average time since the first 
symptom had appeared was (mean (SD))11.5 
(5.2) years (4-24), while the average time since 
the establishment of the diagnosis was (mean 
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(SD)) 9.1 (6.7) years (3-20). In 18 of the 22 
patients, a minor salivary gland biopsy had 
been performed. In 17 of these 18 patients, 
histological examination revealed focal lym-
phocytic sialadenitis, meeting the histological 
criteria of SS, while in one patient a negative 
result was obtained. In this latter patient and in 
the four patients on whom no biopsy was per-
formed, the appropriate number of other crite-
ria for the diagnosis of SS was met. All patients 
were regularly followed up. To exclude other 
factors that might possibly influence the 
microcirculatory physiology, SS patients older 
than 60 years, those who had hypertension or 
clinical evidence of arteriosclerosis (coronary 
heart disease, arteriosclerotic cerebral disease 
or arteriosclerosis in other organs) or periph-
eral neuropathy, and those who regularly took 
P-adrenergic blockers, calcium channel block-
ers, pentoxyphylline, or other drugs with 
vasodilatory or anticholinergic properties, were 
regarded as not eligible for the study. For the 
same reason, the use of non-steroidal anti-
inflammatory drugs was suspended at least five 
days before the examinations. The patients 
were asked to refrain from smoking or the 
drinking of coffee on the day of the examina-
tion. 
Twelve healthy, age and sex matched people 
were examined as controls. None of these sub-
jects had any known illness, or were taking any 
regular medication. All gave their informed 
consent to the procedure and the study design 
was accepted by the Medical Ethics Board of 
Albert Szent-Györgyi Medical University. 
EXAMINATION OF THE CUTANEOUS VASCULAR 
RESPONSE 
During examinations, the patients and controls 
were in the supine position. The skin blood 
flow (SBF) was measured with a laser-Doppler 
flowmeter (Penflux, Perimed) attached to the 
skin on the flexor surface of die right forearm, 
and blood flow values were expressed in 
arbitrary units." Three ECG electrodes were 
attached to the chest and the heart rate was 
monitored continuously, as was the blood 
pressure by means of a photoplethysmographic 
blood pressure monitor (Finapres 2300, Ohm-
eda) attached to a finger of the right hand (beat 
to beat registration). The subjects were asked 
to lie at rest with their eyes closed. The room 
temperature was kept constant (20°C ± 1°C) 
and all disturbing factors were excluded. The 
baseline SBF was recorded for five minutes) the 
blood flow was stable by the end of this period 
and the SBF value measured at five minutes 
was defined as SBF basal. Then 0.1 ml of car-
bachol (Miostat, Alcon, USA), a muscarinic 
receptor agonist, was injected intracutaneously 
into the forearm skin. As control, almost 
simultaneously, 0.1 ml of 0.9% saline solution 
was injected similarly into the forearm skin at 
approximately 10 cm from the other injection 
site. SBF was measured simultaneously at the 
two injection sites for another 10 minutes and 
the highest deviations from the baseline flow 
values were designated SBF final. 
All recorded data (heart rate, systolic and 
diastolic arterial pressure and SBF) were 
stored in a computer database and were 
analysed by means of a self developed software. 
The change in SBF in response to the injection 
of carbachol (dSBF) was calculated using the 
following formula: 
SBFfinal, carbachol/SBFbasal, carbachol 
dSBF — 
SBFfinal, saline/SBFbasal, saline 
Thus, dSBF is the ratio of the SBF values 
measured after and before the injection of car-
bachol divided by the same ratio for the control 
solution of physiological saline. This calcula-
tion allowed us to eliminate the absolute flow 
values and also to eliminate possible non-
specific microcirculatory effects of the intracu-
taneous injection. In every subject, the mean 
values of the RR intervals on the ECG, and the 
systolic, diastolic and mean arterial pressures 
were also recorded. The cutaneous vascular 
resistance (CVR) was calculated by dividing 
the mean arterial pressure by SBF, while dCVR 
was calculated with a formula analogous to that 
for dSBF. 
LABORATORY EXAMINATIONS 
Laboratory examinations were performed as 
follows: anti-SSA and anti-SSB antibodies: 
enzyme linked immunosorbent assay (Ep-
ignost, Leonding/Linz, Austria)) antinuclear 
antibodies: indirect immunofluorescence assay, 
using rat liver as substrate) IgM rheumatoid 
factor: quantitative measurements by immuno-
turbidimetry (Boehringer Mannheim, Ger-
many). HLA D R B l , DQA1 and DQBl 
genotyping was performed by using methods 
described in detail by others.""20 Schirmer's 
test and sialometry were performed within one 
year from the examinations in all SS patients. 
As sialometric examination, we assessed the 
unstimulated whole saliva production in 10 
minutes. Skin dryness was scored on a scale 
0-IV on the basis of the patients' reports of the 
severity of dry skin complaints and physical 
examination of the skin, as follows: grade 0: no 
dry skin) grade I: a transient feeling of skin 
dryness not requiring treatment, and no objec-
tive signs of dry skin) grade II: a recurrent feel-
ing of skin dryness requiring treatment with 
hydrating lotions, and objective signs of 
Table I Occurrences of main organ manifestations and 
laboratory variables in primary Sjögren's syndrome 
patients (:h=22') 
Organ manifestations and laboratory variables 
Number of 
patients (%) 
Articular involvement* 17 (77) 
Renal involvement! 4(18) 
Bronchitis sicca 4(18) 
Pulmonary fibrosis 2(9) 
Raynaud's phenomenon 6(27) 
Skin vasculitis 3(14) 
MALT lymphoma in parotid gland 2(9) 
Anaemia! 6(27) 
Hypergammaglobulinemias IS (68) 
Antibody positivity 
Anti-SSA 14 (64) 
Anti-SSB 9(41) 
IgM rheumatoid factor 18(82) 
Antinuclear antibody 18 (82) 
'Clinically evident arthritis or persistent arthralgia without 
objective physical signs. ¿Chronic tubulointerstitial nephritis or 
renal tubular acidosis. ¿Haemoglobin <100 g/1 not attributable 
to causes other than SS. $y globulin >16 g/1. 
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Table 2 Comparison of certain haemodynamic variables in primary Sjogren's syndrome (SS) patients and controls recorded during the blood flow 
examinations 
SBFfinal,carbachol! SBFfinal, saline! Mean SBP Mean MBP Mean DBP 
Group SBFbasal,carbachol SBFbasal,saline dSBF dCVR Mean RR (msec) (mm Hg) (mm Hg) (mm Hg) 
SS patients 1.89 (1.05)* 0.94 (0.29) 2.07 (1.12)f 0.64 (0.32)i 827.9 (109.6) 132.4 (22.0) 95.9 (16.5) 76.3 (14.9) 
Controls 2.72 (1.27) 0.86 (0.19) 3.30 (1.79) 0.38 (0.17) 797.0 (117.3) 128.6 (14.9) 93.8 (9.8) 74.9 (7.5) 
Data shown as mean (SD). SBF: skin blood flow; CVR; cutaneous vascular resistance; RR: RR interval on ECG; SBP: systolic arterial blood pressure; MBP: mean 
arterial blood pressure; DBP: diastolic arterial blood pressure. SBF and CVR values are in arbitrary units. For the calculation of dSBF and dCVR, see the text (Meth-
ods section). *p=0.048, fp=0.019, $p=0.013. 
decreased sweat production; grade III: a 
continuous feeling of skin dryness revealed by 
topical treatment, and severely dry skin with 
fine scaling; grade IV: a continuous feeling of 
skin dryness not revealed by topical treatment, 
and very severely dry skin with excoriations 
and mild loss of hair. 
STATISTICAL ANALYSIS 
Differences between means were calculated 
with an independent sample t test, except for 
the comparison of the means of dSBF values, 
where Wilcoxon's t test was applied because of 
the non-parametric distribution of the ele-
ments of the samples. For the comparisons of 
frequencies, Fisher's exact test was used, with 
Bonferroni's correction when the examined 
variable had more than two possible values (for 
example, HLA genotype). To investigate corre-
lations with dSBF, Spearman's signed rank test 
or linear regression analysis was applied. 
Statistical calculations were performed with 
SPSS software. Values in the text are expressed 
as mean (SD). T h e level of significance was 
defined as p<0.05. 
Results 
Table 1 gives details relating to the occurrences 
of the main systemic organ manifestations of 
SS and the various laboratory parameters in 
the 22 patients. 
Table 2 reports the average values of the 
most important haemodynamic variables in the 
two groups recorded during the examinations 
of the cutaneous microcirculation. We present 
here the means of the changes in the local 
blood flow in response to carbachol 
(SBFfinal,carbachol/SBFbasal,carbachol) and 
physiological saline solution (SBFfinal,saline/ 
SBFbasal,saline), the dSBF values (which are 
specific indicators of the cutaneous vasodilata-
tion in response to the cholinergic agonist), and 
also the corresponding values of the change in 
CVR. T h e means of the continuously recorded 
values of the RR intervals on the E C G and of 
systemic arterial blood pressure are also 
included in table 2. 
In the event of a positive vascular reaction, 
the blood flow started to increase within 30 
seconds after the injection of carbachol and 
reached a new steady state approximately 4 -7 
minutes later, then remaining unchanged until 
the end of the examination. In the controls, the 
average dSBF was 3.30 (1.79), which was sig-
nificantly higher than the average dSBF in SS 
patients (2.07 (1.12)) (p=0.019) (fig 1). In the 
controls, the dSBF values reflected a 1.66-7.6-
fold increase in microcirculatory blood flow 
after the injection of carbachol. However, in a 
relatively high proportion of the SS patients, 
the reaction to the administration of carbachol 
was small or virtually absent, while in other 
patients a marked vasodilatation was observed. 
We defined a positive microvascular reaction to 
carbachol in the SS patients as a dSBF value 
higher than the smallest dSBF value in the 
group of healthy controls. Following this 
definition, exactly half of the SS patients (11 of 
22) could be considered to be non-
responders—that is, producing a less than 
1.66-fold increase in the microcirculatory 
blood flow—while the other half of the patients 
were regarded as responders to carbachol on 
m 
SS patients 
m 
m 
x> 
t « 
Controls 
Figure 1 Distribution of dSBF values in primary Sjogren's syndrome (SS) patients and healthy controls. dSBF: change 
in skirt blood flow in response to the injection of carbachol. Continuous lines indicate means. Values above the dashed lines 
indicate a positive response to carbachol. 
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Table 3 Demographic characteristics and occurrences of certain organ manifestations of 
primary Sjogren's syndrome CSS) in carbachol responder and non-responder SS patients 
Responders (n-11) Non-responders (n-tl) 
Average age (y) 51.0 50.3 
Average time since first symptom (y) 11.8 11.2 
Articular involvement 9 8 
Renal involvement 3 1 
Bronchitis sicca 3 1 
Pulmonary fibrosis 1 1 
Raynaud's phenomenon 5 1 
Skin vasculitis 2 1 
MALT lymphoma in parotid gland 2 0 
For organ manifestations, numbers indicate the number of involved patients. For the precise defi-
nitions of articular and renal involvement, see table 1. No significant difference was found between 
the two subgroups. 
Table 4 Numbers of people with various degrees of 
severity of skin dryness among the primary SjSgren's 
syndrome patients (n=22) 
Degree of skin dryness 0 I H III IV 
Number of patients 5 4 6 7 0 
For a precise dcscripdon of the assessment of the severity of skin 
dryness, see the text (Methods scction). 
the basis of the pronounced vasodilatation (a 
more than 1.66-fold increase in SBF). 
We examined whether there was any differ-
ence in certain demographic characteristics or 
in the frequencies of certain clinical organ 
involvements between the SS patients defined 
as non-responders or as responders to carba-
chol (table 3). The age of the patients and the 
time since the appearance of the first symptom 
of SS was similar in the two groups. Similarly, 
when tested by linear regression analysis, the 
above variables did not demonstrate any corre-
lation with dSBF (data not shown). No statisti-
cally significant difference was revealed be-
tween the two groups in the occurrence of any 
of the main organ manifestations. However, it 
is noteworthy that all the examined organ 
involvements occurred more frequently in the 
responder patients (with the exception of 
pulmonary fibrosis, which occurred in one 
patient in each of the subgroups) (table 3). Dry 
skin is a common complaint in SS patients. In 
table 4, we present the proportions of patients 
with varying degrees of severity of skin dryness. 
We checked whether there was a correlation 
between the reactivity of the cutaneous micro-
circulatory vessels to carbachol (dSBF) and the 
degree of skin dryness, which is predominantly 
a consequence of the insufficiency of the 
exocrine glands of the skin; the answer proved 
negative. The two subgroups were also compa-
rable as concerns the average values of tear and 
saliva production (mean tear flow with Schirm-
er's test: 4.0 (2.12) v 4.45 (2.21) mm/5 
minutes, unstimulated whole saliva flow: 0.34 
(0.28) v 0.32 (0.28) ml/10 minutes in the non-
responders and in the responders, respec-
tively). 
The frequencies of anti-SSA, anti-SSB, IgM 
RF and ANA positivity, and also the average 
levels of laboratory markers of a chronic 
autoimmune inflammatory process, in particu-
lar the erythrocyte sedimentation rate, fibrino-
gen concentration, anaemia and y globulin 
concentration, did not differ significantly in the 
two subgroups of primary SS patients. No 
HLA DR, DQA1 and DQB1 allele occurred 
more frequently in one subgroup than in the 
other, although, in view of the relatively small 
number of patients and the heterogeneity of the 
genotypes of the examined persons, a statisti-
cally significant difference is hardly to be 
expected (data not shown). 
The drug treatment applied throughout the 
course of the illness was also surveyed. The 
proportions of patients treated with non-
steroidal anti-inflammatory drugs, hydroxy-
chloroquine or corticosteroids were similar in 
the two subgroups. Two patients were receiving 
regular corticosteroid treatment and five hy-
droxychloroquine treatment at the time of the 
examination; the use of these drugs did not 
seem to influence the microcirculatory re-
sponse to carbachol, as indicated by the similar 
proportions of users in the responder and non-
responder subgroups. 
Discussion 
The purpose of this study was to determine the 
proportion of primary SS patients who demon-
strate signs of a cholinergic dysfunction, and to 
evaluate whether there is a relation between the 
presence of a cholinergic dysfunction and cer-
tain clinical, serological and genetic character-
istics of the disease. The importance of this 
question stems from the fact that the salivary 
glands are richly innervated by cholinergic 
nerve fibres, and, if the hypothesis that there is 
a disturbance in the cholinergic innervation 
proves true; this may provide new aspects as 
regards the pathogenesis of the sicca symptoms 
in SS. The issue of abnormalities in the 
parasympathetic nervous system in SS has 
arisen in previous human or animal studies in 
which various stages of the parasympathetic 
innervation pathway were investigated. Mandl 
et at and Andonopoulos et at detected 
autonomic neuropathy, mainly affecting the 
parasympathetic nerves. Santavirta et at dem-
onstrated that the salivary outputs of VIP 
(considered a marker of the parasympathetic 
innervation) and of neuropeptide Y (a marker 
of sympathetic innervation) were both in-
creased as compared with healthy controls. 
They suggested that this phenomenon is asso-
ciated with an altered response to stress in SS 
patients. In immunohistological examinations, 
Konttinen et at found that VIP containing 
parasympathetic fibres were absent from re-
gions of the parotid glands where inflammatory 
cell infiltration and acinar atrophy were severe. 
Circulating antibodies against rat parotid M3 
muscarinic cholinergic receptors were detected 
by Bacman et alt Tornvall et at reported that 
the expression of the P„ and a isoforms of pro-
tein kinase C, a crucial member of the intracel-
lular second messenger pathway of cholinergic 
neurotransmission, was deficient on the sali-
vary gland acinar epithelial cells in SS patients 
as compared with controls. In contrast with 
healthy controls, the % and P„ isoforms were 
undetected on the myoepithelial cells in SS 
patients. These findings are suggestive of a 
postreceptorial disturbance of the cholinergic 
innervation. 
In this study, we examined the cutaneous 
cholinergic vasodilatation in SS patients in 
response to the local administration of a 
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muscarinic cholinergic agonist, carbachol. Ace-
tylcholine has been demonstrated to cause 
vasodilatation in healthy humans.13 Although 
the non-adrenergic-non-cholinergic transmit-
ter systems probably play a more important 
part in the physiological vasoregulation in the 
skin than do the cholinergic nerves, receptors 
for acetylcholine can also be found in the cuta-
neous microvasculature.21 Carbachol has been 
demonstrated to induce phospholipase C 
dependent saliva secretion through stimulation 
of the muscarinic cholinergic receptors in 
human salivary acinar cells.22 23 The same mus-
carinic receptors have been implicated in the 
cholinergic vasodilatation in human cutaneous 
arterioles in response to body heat stress.13 
These findings provide a basis for our choice of 
an investigation of the cutaneous microcircula-
tion as a model of the parasympathetic 
innervation of the salivary glands. Neverthe-
less, firm conclusions can be drawn only after 
examinations directly involving the salivary 
glands in SS patients. 
We found that the average increase in 
cutaneous microcirculatory blood flow in 
response to carbachol was significandy smaller 
in the SS patients than in the healthy controls. 
In half of the SS patients, the reacuon to a 
potent parasympathomimetic drug was virtu-
ally absent or markedly diminished. As va-
sodilatation is characterised physiologically by 
a decrease in vascular resistance, the CVR was 
also calculated by dividing the mean arterial 
pressure by SBF. As the arterial pressure 
remained virtually unchanged in all the exam-
ined persons during the examinations, an 
increase in SBF always reflected cutaneous 
vasodilatation in this experimental setting. 
The above finding lends support to previous 
results suggesting a disturbance in the para-
sympathetic autonomic nervous system in SS. 
As our experiments involved the administra-
tion of a muscarinic receptor agonist directly to 
the examined target organ, the detected 
unresponsiveness favours the hypothesis that a 
dysfunction may exist at a receptorial or 
post-receptorial level. To test whether a recep-
torial dysfunction may result from a structural 
abnormality of the receptor protein caused by 
an abnormal genetic coding, we determined 
the HLA DRB1, DQA1 and DQBl genotype 
profiles in our study patients. Certain HLA 
alleles (most importantly HLA-DR3) are 
known to occur more frequently in SS patients 
than in the general population. However, the 
hypothesis that an acetylcholine receptor pa-
thology may be determined by a genetic 
predisposition remains an open question, as 
our relatively small patient population does not 
allow firm conclusions in this regard. Anti-
receptor antibodies, similarly to myasthenia 
gravis, may be other possible causes of a recep-
tor dysfunction. Indeed, antibodies against rat 
M, muscarinic receptors have been detected in 
SS patients,' though the existence and possible 
role of anti-receptorial antibodies against 
human muscarinic receptors have not been 
verified. 
It has been hypothesised that an interaction 
may occur in the salivary glands between the 
infiltrating inflammatory cells and certain 
neuropeptides.4 In contrast, another hypothesis 
suggests that the loss of trophic stimuli from 
the parasympathetic nerves in the salivary 
glands might be a cause of acinar cell atrophy, 
and this may contribute to the decreased saliva 
production.4 Our results relating to investiga-
tion of a target organ distant from the areas of 
lymphocytic inflammation suggest that a disor-
der of the cholinergic receptors may not be 
restricted to the exocrine glands, but may be a 
more widely occurring phenomenon, and that 
this defect is possibly independent of the local 
inflammatory process. Further investigations 
may yield results of general importance as con-
cerns the interactions between the nervous sys-
tem and the immune system. 
As a considerable proportion of the SS 
patients displayed a fundamentally insignifi-
cant reaction to carbachol, we could divide our 
population of SS patients into responders and 
non-responders to the cholinergic agent. The 
occurrence of unresponsiveness did not corre-
late with the age of the patients, the disease 
duration, the presence of a specific organ 
manifestation (including vascular manifesta-
tions of the disease) or of an autoantibody, nor 
the severity of the functional impairment of the 
salivary and lachrymal glands. However, all the 
organ involvements proved to be more com-
mon in the responder patients than in the non-
responders. Confirmation of this latter finding 
with statistically significant results is first 
necessary before an explanation can be sug-
gested. 
In summary, we found that half of the exam-
ined SS patients proved to be non-responders 
to the administration of the cholinergic recep-
tor agonist carbachol. Whether this unrespon-
siveness also relates to the clinically involved 
exocrine glands, and the precise mechanism of 
the disorder in the cholinergic innervation, 
possibly at a receptorial or postreceptorial 
level, are features that remain to be clarified. 
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Abstract 
Parkinson's disease (PD) and Alzheimer's dementia (AD) are often associated with an autonomic neuropathy. The extent of autonomic 
involvement, however is poorly defined and unpredic table. In order to assess the autonomic cardiovascular regulation baroreflex sensitivity 
(BRS) was determined non-invasively in 23 patients (age: 65 ± 9.3 years) with PD and 24 patients with AD (age: 72.3 ± 7.2 years). The 
results were compared with those on 22 healthy age- and sex-matched volunteers. Patients with PD and AD exhibited marked abnormalities 
in cardiovascular autonomic reflex regulation showed by markedly depressed BRS. The possible predictive value of centrally based 
depression of baroreflex sensitivity necessitates further studies. © 2001 Elsevier Science Inc. All rights reserved. 
Keywords: Parkinson's disease; Alzheimer's dementia; Baroreflex sensitivity 
1. Introduction 
Recently several studies including prospective, random-
ized, multicenter studies have shown that depressed barore-
flex sensitivity (BRS) is an independent predictor for sud-
den cardiac death and life threatening arrhythmias in 
patients with cardiac disease [12]. The ATRAMI investiga-
tors have shown that measurement of BRS is an appropriate 
way to identify patients after myocardial infarction who are 
at high risk of cardiac death or non-fatal cardiac arrest due 
to ventricular fibrillation [12], Increased cardiovascular 
mortality has been reported in patients with Alzheimer's 
dementia (AD) and Parkinson's disease (PD) [2,3,8]. The 
aim of the present study was to assess the BRS in patients 
in whom the baroreflex arch is possibly centrally damaged. 
* Corresponding author. Tel.: +31-10-4633991; fax: +31-10-
4634420. 
E-mail address: szili@card.azr.nl (T. Szili-Torok). 
2. Methods . 
2.1. Patient population 
We assessed the BRS in 23 patients with PD and 24 
patients with AD, who were recruited from the Parkinson's 
Clinic and the Dementia Clinic of the Neurology and Psy-
chiatry Departments at Albert Szent-Györgyi Medical Uni-
versity. Patients without history of any cardiovascular dis-
ease, who under physical examination showed no 
abnormalities and had a normal 12-lead ECG were selected 
for this study. Clinical characteristics of the patients are 
shown in the Table. We excluded patients with any other 
medical condition which was likely to affect baroreceptor 
regulation. 76% of the PD patients were on L-DOPA, 63% 
on an M A O inhibitor, 25% on an anticholinergic drug, 67% 
on amantadine and 31% on bromocryptine. 36% of the 
patients took antidepressants and 15% beta-blockers. AD 
patients stopped all of their medication 5 half-life time 
before the measurements. There was a control group of age 
and sex matched healthy individuals (C). 
0197-4580/01/S - see front matter © 2001 Elsevier Science Inc. All rights reserved. 
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Table 1 
Clinical characteristics, neurodiagnostic test scores and comparison of baroreflex sensitivities of probands 
Control Alzheimer's disease p values Parkinson's disease p values 
Age (year 70 ± 6.6 72.3 ± 7.2 >0.05 65 ± 9.3 >0.05 
Sex (M/F) 7/15 9/14 — 11/13 — 
Age of onset disease (year) — 66.9 ± 7.4 — 58.9 ± 9 — 
MMSE 29 ± 0.9 19 ± 6.5* <0.05 27.5 ± 2 >0.05 
UPDRS — — — 26.7 ± 20.3 — 
HY — — — 2.1 ± 0.8 — 
dRR (ms) 36.4 ± 7.2 19.6 ± 4.7* <0.01 21.4 ± 6.7* <0.01 
dBP (mm Hg) 4.4 ± 2.3 6.4 ± 2.1* <0.05 5.7 ± 2.2* <0.05 
BRS (msec/mm Hg) 8.9 ± 6.9 2.6 ± 1.1* <0.001 4.3 ± 3.5* <0.05 
Data are mean ± SD; M = male; F = female; MMSE = Modified Mini Mental State Examination; UPDRS = Unified Parkinson's Disease Rating Scale; 
HY = Modified Hoehn and Yahr staging; BRS = Baroreflex sensitivity; dRR = RR interval oscillation; dBP = systolic arterial blood pressure oscillation; 
* significant vs. Control, p values are shown vs. Control. 
2.2. Measurements and calculations 
All measurements were conducted in the afternoon 4 - 5 
h after the last meal. The participants were requested to 
avoid smoking and to refrain from caffeine-containing bev-
erages 6 h prior to the examinations. The ECG and the 
breathing were continuously recorded with a Sirecust 730 
(Siemens) monitor. Blood pressure (BP) was measured non-
invasively with a Finapres 2300 (Ohmeda) device, which 
reliably reflects BP changes. BP and HR measurements 
were monitored in a supine rest position for 60 min. The 
photo-plethysmographic (Penaz system) finger blood pres-
sure monitor reconstructs a continuous BP curve that 
closely follows the invasively recorded BP fluctuations. The 
R wave of the ECG and the plethysmographic signals were 
fed through an amplifier, filter and analog-digital converter 
into an IBM-AT-compatible computer. The computer mea-
sured the interval between successive R waves with a pre-
cision of 2 ms. The accuracy of BP signal detection was 1 
mm Hg. The cardiotachogram and trend-grams of the BP 
values were continuously recorded on-line. BRS was char-
acterized by the spontaneous sequences method. It has been 
established that 3 or more cardiac cycles of unidirectional 
BP increase or decrease with the corresponding lengthening 
or shortening of the interbeat intervals to form spontaneous 
"up" or "down-sequences." These sequences are analogous 
to those induced by pharmacological maneuvers, and a 
spontaneous BRS could be determined as an average of 
several individual slopes. In this study, all of the changes in 
systolic BP (delta SBP) were paired with the changes in the 
subsequent RR intervals (delta RR). This method is referred 
as the lagl technique [15]. Oscillations in HR (dHR) and BP 
(dBP) were calculated over the same 60-min period. 
2.3. Statistical analysis 
One way ANOVA was used for comparison of data 
showing normal distribution (age, BRS, Age of onset,). T 
tests with Bonferroni correction were used for comparisons 
between groups. Level of significance was set at P < 0.05. 
3. Results f 
The average RR interval length was shorter in both of the 
PD and AD groups than in the healthy volunteers (C: 855 ± 
100 msec, PD: 689 ± 140 msec, AD: 697 ± 110 msec, P < 
0.01 vs. C). The systolic blood pressure, however, was very 
similar in all three groups (C: 126 ± 21 mm Hg, PD: 117 ± 
17 mm Hg, AD: 118 ± 22 mm Hg). BRS was markedly 
reduced in the AD and PD groups compared with C (Table). 
There was no statistically significant difference between the 
AD and PD group in BRS values (Table). Patients with AD 
and PD showed significantly decreased dRR, and increased 
dBP compared with C (Table). There was no statistical 
difference between AD and PD patients in dRR and dBP. 
4. Discussion 
The major observation of our study is that baroreflex 
regulation is markedly depressed in Alzheimer's dementia 
and Parkinson's disease, characterized by a significant de-
crease in BRS. 
4.1. Measurement of BRS in patients with AD and PD 
The examination of spontaneous BRS involves a nonin-
vasive procedure that does not need the active cooperation 
of the patients and it can therefore be used with disabled or 
weak patients too. Our results demonstrate that the proce-
dure is suitable for screening autonomic involvement 
among patients with PD and AD. Basal HR of the patients 
with AD and PD was higher than that of healthy volunteers, 
suggesting diminished vagal tone. It seems plausible, that 
the decreased vagal tone in these subjects is related to their 
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abnormally low BRS. Vagal tone however could be gener-
ated by both baroreflex-dependent and baroreflex-indepen-
dent mechanisms [11]. The integrity of the latter was not 
addressed in our study. Increased basal HR may also indi-
cate, that the resting point on the sigmoid baroreflex re-
sponse curve is located close to the saturation region (i.e. 
the upper flat portion of the relationship). BRS methods 
based on spontaneous blood pressure fluctuations do not 
describe the whole sigmoid baroreflex curve [17], This 
relationship could have been depicted only by the neck 
chamber technique, a method extremely unsuited to these 
patient populations. The pharmacological baroreflex meth-
ods are often regards as gold standard techniques, however 
recent evidence points to considerable limitations in their 
use [4,16], Nevertheless, the baroreflex gains yielded by the 
different methods are closely related, and the method of 
spontaneous sequences may gain further acceptance in the 
future [17], 
4.2. Mechanism of depressed BRS in patients with AD 
and PD 
Early morphological studies have indicated damage to 
important blood pressure and baroreflex regulatory centers 
in AD and PD [6]. Recently, damage to autonomic-related 
cortices, which can contribute autonomic imbalance often 
associated with AD was described in detail [5], However, 
the reason of the autonomic imbalance remained unknown 
in patients with such neurological disorders. The determi-
nation of the BRS by a spontaneous sequences method [15] 
might be related to respiration. The genesis of this complex 
mechanism is a result of an interplay between the most 
important blood pressure regulatory mechanisms such as 
central cardiorespiratory coupling, reflexes from pulmonary 
stretch receptors, arterial baroreflexes, reflexes from the 
cardiac (low pressure) receptors. The relative roles of these 
mechanisms remain unclear. Therefore damage to any of 
these reflexes may influence the measured value of BRS. 
Patients with AD showed decreased heart rate variability 
and this was associated with increased acethyl-choline es-
terase activity. Although the involvement of afferent nerves 
can not be excluded, these results suggest that the peripheral 
efferent autonomic system may play a role in the presence 
of cardiac autonomic dysfunction superimposed by signifi-
cant damage to central autonomic structures [5,6,14]. De-
creased BRS may reflect cholinergic deficits in the cardiac 
autonomic nerves as well as in the central nervous system 
[14], In contrast with previous findings, the diminished HR 
oscillation during normal breathing (indicated by decreased 
dRR) was associated with increased BP oscillation in both 
groups in this study [13]. BRS in PD was first examined by 
Appenzeller and Goss. They concluded that BRS was patho-
logical in some PD patients [1]. Our study confirms this and 
demonstrates more general aspects of this early observation. 
The function of the HR changes is commonly known to 
buffer changes in BP. Accordingly, it is not surprising that 
the amplitude of BP surge increases with decreasing HR 
fluctuation [10]. The significance'of the abnormalities in 
cardiovascular regulation among AD and PD patients is not 
yet fully known. It is possible that the imbalance of the 
sympathetic and the parasympathetic tone is connected with 
the ischemic heart muscles. The pathological BRS that 
signaled an autonomic imbalance in the acute phase of 
myocardial infarction was a sensitive predictor of ventric-
ular arrhythmias and sudden death [12], 
4.3. Possible clinical implications 
The known central abnormalities in AD and PD would 
be consistent with the deficient baroreflex regulation in 
these patients originating centrally. Large scale clinical tri-
als indicate that a decreased baroreflex gain is a predictor of 
adverse outcome in congestive heart failure and in acute 
myocardial infarction [12], but the significance of the ab-
normal baroreflex gain in neurological disorders is unclear. 
The connection between autonomic dysregulation and ar-
rhythmia-related death has recently been considered in 
other, non-cardiovascular diseases, such as depression [7]. 
Analogously, we can presume a connection between the 
autonomic imbalance and the high mortality among Parkin-
son's disease patients [2,3]. Increased mortality in Parkin-
son's disease patients due to ischemic heart disease was 
reported recently [2,3]. Increased cardiovascular mortality 
has also been reported in patients with Alzheimer's demen-
tia associated with a tendency to lower blood pressure [9]. 
The mortality of Parkinson's disease patients is almost 
twice that for age and sex-matched healthy control groups 
[2]. The 20-year follow-up study by Ben-Shlomo and Mar-
mot suggested that this increased mortality is connected 
with an increase in heart ischemia related deaths [3], How-
ever, this study did not distinguish sudden cardiac deaths, 
and thus the real importance of arrhythmia-related deaths 
could not be assessed. Hence, the possible predictive value 
of centrally based depression of baroreflex sensitivity ne-
cessitates further studies. 
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